NIH Grants that mention Trastuzumab (marketed as Herceptin by Roche), RePORT 9 December 2010
Project Title Project Number Project Start Date Budget Start Date Budget End Date FY Contact Principal Investigator Organization Name Organization City Organization State Organization Country Administering IC Total Cost NIH Spending Categorization
BREAST CANCER 3U10CA025224-23S1 2002-01-01 1998-10-01 30-Sep-99 2002 PEREZ, EDITH A MAYO CLINIC COLL OF MEDICINE, ROCHESTER ROCHESTER MN UNITED STATES NCI $78,870 No NIH Category available.
BREAST CANCER 5U10CA025224-23 2002-01-11 1998-10-01 30-Sep-99 2002 PEREZ, EDITH A MAYO CLINIC COLL OF MEDICINE, ROCHESTER ROCHESTER MN UNITED STATES NCI $78,870 No NIH Category available.
SPECIFIC IMMUNOTHERAPY WITH MONOCLONAL ANTIBODIES 2R01CA039930-15 1988-09-30 2001-04-01 31-Mar-02 2001 BAST, ROBERT C UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $249,000 No NIH Category available.
COEXPRESSION OF EGFRVLLL/ERBB2 IN HUMAN BREAST CANCER 1R01CA088871-01A1 2001-09-01 2001-09-01 31-Aug-02 2001 TANG, CAREEN K GEORGETOWN UNIVERSITY WASHINGTON DC UNITED STATES NCI $257,632 No NIH Category available.
MECHANISM BASED EVALUATIONS OF ERBB TARGETED AGENTS 1U54CA090788-01 2001-09-26 2001-09-26 31-Dec-01 2001 TEMPERO, MARGARET A UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $644,670 No NIH Category available.
SPECIFIC IMMUNOTHERAPY WITH MONOCLONAL ANTIBODIES 5R01CA039930-16 1988-09-30 2002-04-01 31-Mar-03 2002 BAST, ROBERT C UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $249,000 No NIH Category available.
MECHANISM-BASED EVALUATIONS OF ERBB-TARGETED AGENTS 5U54CA090788-02 2001-09-26 2002-05-01 31-Dec-02 2002 TEMPERO, MARGARET A UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $1,180,630 No NIH Category available.
FCR ENHANCED AG PRESENTATION--INDUCTION TUMOR IMMUNITY 1R01CA094037-01 2002-08-01 2002-08-01 31-Jul-03 2002 CLYNES, RAPHAEL A COLUMBIA UNIVERSITY HEALTH SCIENCES NEW YORK NY UNITED STATES NCI $327,409 No NIH Category available.
COEXPRESSION OF EGFRVLLL/ERBB2 IN HUMAN BREAST CANCER 5R01CA088871-02 2001-09-01 2002-09-01 31-Aug-03 2002 TANG, CAREEN K GEORGETOWN UNIVERSITY WASHINGTON DC UNITED STATES NCI $257,632 No NIH Category available.
SIGNALING BY NEUREGULINS AND ERBB4 IN BREAST CANCER 2R01CA080065-04 1998-12-01 2002-09-05 30-Jun-03 2002 STERN, DAVID F YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $377,963 No NIH Category available.
ERBB1 AND ERBB2 BLOCKADE IN ADVANCED BREAST CANCER 1R21CA099250-01 2002-09-23 2002-09-23 31-Aug-03 2002 DE BONO, JOHANN S CANCER THERAPY AND RESEARCH CENTER SAN ANTONIO TX UNITED STATES NCI $278,458 No NIH Category available.
MECHANISM-BASED EVALUATIONS OF ERBB-TARGETED AGENTS 5U54CA090788-03 2001-09-26 2003-01-01 31-Dec-03 2003 TEMPERO, MARGARET A UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $1,213,114 No NIH Category available.
PHASE II DOXORUBICIN/VINORELBINE IN WTP53 BREAST CANCER 1R01CA095275-01A1 2003-02-05 2003-02-05 31-Jan-04 2003 TOPPMEYER, DEBORAH L UNIV OF MED/DENT NJ-R W JOHNSON MED SCH PISCATAWAY NJ UNITED STATES NCI $255,060 No NIH Category available.
SPECIFIC IMMUNOTHERAPY WITH MONOCLONAL ANTIBODIES 5R01CA039930-17 1988-09-30 2003-04-01 31-Mar-04 2003 BAST, ROBERT C UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $249,000 No NIH Category available.
FCR ENHANCED AG PRESENTATION--INDUCTION TUMOR IMMUNITY 5R01CA094037-02 2002-08-01 2003-08-01 31-Jul-04 2003 CLYNES, RAPHAEL A COLUMBIA UNIVERSITY HEALTH SCIENCES NEW YORK NY UNITED STATES NCI $327,409 No NIH Category available.
SIGNALING BY NEUREGULINS AND ERBB4 IN BREAST CANCER 5R01CA080065-05 1998-12-01 2003-08-13 30-Jun-04 2003 STERN, DAVID F YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $376,919 No NIH Category available.
COEXPRESSION OF EGFRVLLL/ERBB2 IN HUMAN BREAST CANCER 5R01CA088871-03 2001-09-01 2003-09-01 31-Aug-04 2003 TANG, CAREEN K GEORGETOWN UNIVERSITY WASHINGTON DC UNITED STATES NCI $257,632 No NIH Category available.
ERBB1 AND ERBB2 BLOCKADE IN ADVANCED BREAST CANCER 5R21CA099250-02 2002-09-23 2003-09-25 30-Sep-03 2003 ROWINSKY, ERIC K CANCER THERAPY AND RESEARCH CENTER SAN ANTONIO TX UNITED STATES NCI $3,269 No NIH Category available.
ERBB1 AND ERBB2 BLOCKADE IN ADVANCED BREAST CANCER 6R21CA099250-03 2002-09-23 2003-10-01 31-Aug-06 2003 TAKIMOTO, CHRIS H CANCER THERAPY AND RESEARCH CENTER SAN ANTONIO TX UNITED STATES NCI $264,086 No NIH Category available.
TAILORED DOSE DOCETAXEL + TRASTUZUMAB IN BREAST CANCER 5M01RR000042-44 2004-03-01 2004-03-01 28-Feb-05 2004 SCHOTT, ANNE F UNIVERSITY OF MICHIGAN AT ANN ARBOR ANN ARBOR MI UNITED STATES NCRR $6,607 No NIH Category available.
PHASE II DOXORUBICIN/VINORELBINE IN WTP53 BREAST CANCER 5R01CA095275-02 2003-02-05 2004-03-10 31-Jan-05 2004 TOPPMEYER, DEBORAH L UNIV OF MED/DENT NJ-R W JOHNSON MED SCH PISCATAWAY NJ UNITED STATES NCI $268,397 No NIH Category available.
MECHANISM-BASED EVALUATIONS OF ERBB-TARGETED AGENTS 5U54CA090788-04 2001-09-26 2004-03-30 31-Dec-04 2004 TEMPERO, MARGARET A UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $1,077,842 No NIH Category available.
SPECIFIC IMMUNOTHERAPY WITH MONOCLONAL ANTIBODIES 5R01CA039930-18 1988-09-30 2004-04-01 31-Mar-07 2004 BAST, ROBERT C UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $249,000 No NIH Category available.
N9831: DOXORUBICIN/CYCLOPHOSPHAMIDE/TAXOL +OR -TRASTUZUMAB FOR BREAST CANCER 2M01RR000096-43 2004-04-20 2004-04-20 31-Mar-05 2004 HOCHSTER, HOWARD S NEW YORK UNIVERSITY SCHOOL OF MEDICINE NEW YORK NY UNITED STATES NCRR $2,033 No NIH Category available.
SIGNALING BY NEUREGULINS AND ERBB4 IN BREAST CANCER 5R01CA080065-06 1998-12-01 2004-07-06 30-Jun-05 2004 STERN, DAVID F YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $376,700 No NIH Category available.
FCR ENHANCED AG PRESENTATION--INDUCTION TUMOR IMMUNITY 5R01CA094037-03 2002-08-01 2004-08-20 31-Jul-05 2004 CLYNES, RAPHAEL A COLUMBIA UNIVERSITY HEALTH SCIENCES NEW YORK NY UNITED STATES NCI $327,409 No NIH Category available.
COEXPRESSION OF EGFRVLLL/ERBB2 IN HUMAN BREAST CANCER 5R01CA088871-04 2001-09-01 2004-09-01 31-Aug-05 2004 TANG, CAREEN K GEORGETOWN UNIVERSITY WASHINGTON DC UNITED STATES NCI $257,632 No NIH Category available.
LCCC 0310 DENDRITIC CELL VACCINE GIVEN WITH TRASTUZUMAB AND VINORELBINE 5M01RR000046-45 2004-12-01 2004-12-01 30-Nov-05 2005 SERODY, JONATHAN STUART UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCRR $5,655 No NIH Category available.
SIGNALING BY NEUREGULINS AND ERBB4 IN BREAST CANCER 3R01CA080065-06S1 1998-12-01 2005-02-01 30-Jun-05 2005 STERN, DAVID F YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $21,902 No NIH Category available.
PHASE II DOXORUBICIN/VINORELBINE IN WTP53 BREAST CANCER 5R01CA095275-03 2003-02-05 2005-02-01 31-Jan-09 2005 TOPPMEYER, DEBORAH L UNIV OF MED/DENT NJ-R W JOHNSON MED SCH PISCATAWAY NJ UNITED STATES NCI $268,397 No NIH Category available.
N9831: DOXORUBICIN/CYCLOPHOSPHAMIDE/TAXOL +OR -TRASTUZUMAB FOR BREAST CANCER 5M01RR000096-44 2005-04-01 2005-04-01 31-Mar-06 2005 HOCHSTER, HOWARD S NEW YORK UNIVERSITY SCHOOL OF MEDICINE NEW YORK NY UNITED STATES NCRR $26,259 No NIH Category available.
PH I STUDY OF EGFR AND HER2 BLOCKADE W OSI-774, TRASTUZUMAB AND PACLITAXEL 5M01RR001346-24 2005-04-01 2005-04-01 31-Mar-06 2005 TOLCHER, ANTHONY W UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT SAN ANTONIO TX UNITED STATES NCRR $45,529 No NIH Category available.
MODULATION BY BOTANICALS OF ANTIBODY BASED CANCER IMMUNO 1P50AT002779-01 2005-04-01 2005-04-01 31-Mar-06 2005 CHEUNG, NAI-KONG V SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCCAM $280,773 No NIH Category available.
MULTIMODALITY THERAPY FOR METASTATIC BREAST CANCER 1R21CA105837-01A2 2005-04-15 2005-04-15 31-Mar-06 2005 SERODY, JONATHAN STUART UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCI $288,350 No NIH Category available.
BREAST CANCER RESPONSE MARKERS TO A DUAL HER1/2 BLOCKER 1R01CA112305-01A1 2005-06-16 2005-06-16 31-May-06 2005 CHANG, JENNY C-N BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $266,021 No NIH Category available.
SIGNALING BY NEUREGULINS AND ERBB4 IN BREAST CANCER 5R01CA080065-07 1998-12-01 2005-07-01 30-Jun-06 2005 STERN, DAVID F YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $376,474 No NIH Category available.
SIGNALING BY NEUREGULINS AND ERBB4 IN BREAST CANCER 3R01CA080065-07S1 2005-02-01 2005-07-01 30-Jun-06 2005 STERN, DAVID F YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $30,663 No NIH Category available.
FCR ENHANCED AG PRESENTATION--INDUCTION TUMOR IMMUNITY 5R01CA094037-04 2002-08-01 2005-08-01 31-Jul-06 2005 CLYNES, RAPHAEL A COLUMBIA UNIVERSITY HEALTH SCIENCES NEW YORK NY UNITED STATES NCI $327,409 No NIH Category available.
COEXPRESSION OF EGFRVLLL/ERBB2 IN HUMAN BREAST CANCER 5R01CA088871-05 2001-09-01 2005-09-01 31-Aug-06 2005 TANG, CAREEN K GEORGETOWN UNIVERSITY WASHINGTON DC UNITED STATES NCI $257,632 No NIH Category available.
BLOOD TEST DETECTS CHANGE FROM HER2- TO+IN BREAST CANCER 1R01CA101790-01A3 2005-09-01 2005-09-01 31-Aug-06 2005 UHR, JONATHAN W UNIVERSITY OF TEXAS SW MED CTR/DALLAS DALLAS TX UNITED STATES NCI $266,900 No NIH Category available.
MECHANISM-BASED EVALUATIONS OF ERBB-TARGETED AGENTS 5U54CA090788-05 2001-09-26 2005-09-15 31-Dec-05 2005 TEMPERO, MARGARET A UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $987,374 No NIH Category available.
FATTY ACID SYNTHASE /MOLECULAR TARGET /BREAST CANCER THE 1R01CA116623-01 2005-09-16 2005-09-16 30-Jun-06 2005 LUPU, RUTH NORTHSHORE UNIV HEALTHSYSTEM RES INST EVANSTON IL UNITED STATES NCI $416,745 No NIH Category available.
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 3P50CA089393-06S1 2000-09-30 2005-09-21 31-Aug-06 2005 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $50,000 No NIH Category available.
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 3P50CA089393-06S2 2000-09-30 2005-09-21 31-Aug-06 2005 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $74,999 No NIH Category available.
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 3P50CA089393-06S3 2000-09-30 2005-09-21 31-Aug-06 2005 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $224,999 No NIH Category available.
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 2P50CA089393-06 2000-09-30 2005-09-21 31-Aug-06 2005 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $2,299,999 No NIH Category available.
UTMDACC SPORE IN BREAST CANCER 1P50CA116199-01 2005-09-23 2005-09-23 31-Aug-06 2005 HORTOBAGYI, GABRIEL N UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $2,300,000 No NIH Category available.
LCCC 0310 DENDRITIC CELL VACCINE GIVEN WITH TRASTUZUMAB AND VINORELBINE 5M01RR000046-46 2005-12-01 2005-12-01 30-Nov-06 2006 SERODY, JONATHAN STUART UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCRR $8,673 No NIH Category available.
ROLE OF NEUREGULIN/ERBB SIGNALING IN THE ADULT HEART 2R01HL068144-05A1 2001-09-30 2006-04-01 30-Jun-06 2006 SAWYER, DOUGLAS B BOSTON MEDICAL CENTER BOSTON MA UNITED STATES NHLBI $124,579 No NIH Category available.
P III TRIAL OF DOXORUBICIN & CYCLOPHOSPHAMIDE FOL BY WEEKLY PACLITAXEL W/WO TRAS 5M01RR010732-12 2006-04-01 2006-04-01 31-Mar-07 2006 RYBKA, WITOLD B. PENNSYLVANIA STATE UNIV HERSHEY MED CTR HERSHEY PA UNITED STATES NCRR $18,927 No NIH Category available.
INDIVIDUALIZED TX OF BREAST CANCER BASED ON TUMOR MOLECULAR CHARACTERISTICS 5M01RR000096-45 2006-04-01 2006-04-01 31-Mar-07 2006 FORMENTI, SILVIA C NEW YORK UNIVERSITY SCHOOL OF MEDICINE NEW YORK NY UNITED STATES NCRR $20,576 No NIH Category available.
PH I STUDY OF EGFR AND HER2 BLOCKADE W/ OSI-774, TRASTUZUMAB AND PACLITAXEL 5M01RR001346-25 2006-04-01 2006-04-01 31-Mar-07 2006 TOLCHER, ANTHONY W UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT SAN ANTONIO TX UNITED STATES NCRR $23,191 No NIH Category available.
P III TRIAL OF DOXORUBICIN & CYCLOPHOSPHAMIDE FOL BY WEEKLY PACLITAXEL W/WO TRAS 5M01RR010732-12 2006-04-01 2006-04-01 31-Mar-07 2006 RYBKA, WITOLD B. PENNSYLVANIA STATE UNIV HERSHEY MED CTR HERSHEY PA UNITED STATES NCRR $39,144 No NIH Category available.
PHASE I-II STUDY OF COMBINATION IMMUNOTHERAPY FOR HER-2/NEU CYTOTOXIC T CELLS 5M01RR000037-46 2006-04-01 2006-04-01 31-Mar-07 2006 DISIS, MARY L. UNIVERSITY OF WASHINGTON SEATTLE WA UNITED STATES NCRR $40,522 No NIH Category available.
MODULATION BY BOTANICALS OF ANTIBODY BASED CANCER IMMUNO 5P50AT002779-02 2006-04-01 31-Mar-07 2006 CHEUNG, NAI-KONG V SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCCAM $279,042 No NIH Category available.
MULTIMODALITY THERAPY FOR METASTATIC BREAST CANCER 5R21CA105837-02 2005-04-15 2006-05-31 31-Mar-08 2006 SERODY, JONATHAN STUART UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCI $281,574 No NIH Category available.
BREAST CANCER RESPONSE MARKERS TO A DUAL HER1/2 BLOCKER 5R01CA112305-02 2005-06-16 2006-06-01 30-Apr-07 2006 CHANG, JENNY C-N BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $259,769 No NIH Category available.
SIGNALING BY NEUREGULINS AND ERBB4 IN BREAST CANCER 5R01CA080065-08 1998-12-01 2006-07-01 30-Nov-08 2006 STERN, DAVID F YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $367,399 No NIH Category available.
ANALYSIS OF CIRCULATING TUMOR CELLS IN A PHASE I/II STUDY FOR BREAST CANCER 1R21CA121541-01 2006-07-07 2006-07-07 30-Jun-07 2006 SWABY, RAMONA F FOX CHASE CANCER CENTER PHILADELPHIA PA UNITED STATES NCI $273,173 No NIH Category available.
FCR ENHANCED AG PRESENTATION--INDUCTION TUMOR IMMUNITY 5R01CA094037-05 2002-08-01 2006-08-01 31-Jul-07 2006 CLYNES, RAPHAEL A COLUMBIA UNIVERSITY HEALTH SCIENCES NEW YORK NY UNITED STATES NCI $319,714 No NIH Category available.
MECHANISM-BASED EVALUATIONS OF ERBB-TARGETED AGENTS 5U54CA090788-06 2001-09-26 2006-08-22 31-Dec-08 2006 TEMPERO, MARGARET A UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $467,532 No NIH Category available.
FATTY ACID SYNTHASE: CHARACTERIZATION AS A NOVEL MOLECULAR TARGET FOR BREAST CAN* 5R01CA116623-02 2005-09-16 2006-08-25 31-May-07 2006 LUPU, RUTH NORTHSHORE UNIV HEALTHSYSTEM RES INST EVANSTON IL UNITED STATES NCI $418,986 No NIH Category available.
ROLE OF NEUREGULIN/ERBB SIGNALING IN THE ADULT HEART 7R01HL068144-06 2001-09-30 2006-09-01 31-Mar-07 2006 SAWYER, DOUGLAS B VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NHLBI $237,671 No NIH Category available.
BLOOD TEST DETECTS CHANGE FROM HER2- TO+IN BREAST CANCER 5R01CA101790-02 2005-09-01 2006-09-01 31-Aug-07 2006 UHR, JONATHAN W UNIVERSITY OF TEXAS SW MED CTR/DALLAS DALLAS TX UNITED STATES NCI $260,628 No NIH Category available.
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 3P50CA089393-07S1 2000-09-30 2006-09-26 31-Aug-07 2006 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $703,004 No NIH Category available.
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 5P50CA089393-07 2000-09-30 2006-09-27 31-Aug-07 2006 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $2,245,949 No NIH Category available.
UTMDACC SPORE IN BREAST CANCER 3P50CA116199-02S1 2005-09-23 2006-09-28 31-Aug-07 2006 HORTOBAGYI, GABRIEL N UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $419,559 No NIH Category available.
UTMDACC SPORE IN BREAST CANCER 5P50CA116199-02 2005-09-23 2006-09-28 31-Aug-07 2006 HORTOBAGYI, GABRIEL N UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $2,245,950 No NIH Category available.
CANCER CENTER CORE SUPPORT GRANT 3P30CA016042-33S4 1977-12-01 2006-12-01 1-Apr-09 2007 GASSON, JUDITH CHERYL UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $76,807 No NIH Category available.
CANCER CENTER CORE SUPPORT GRANT 3P30CA016042-33S2 1977-12-01 2006-12-01 1-Apr-09 2007 GASSON, JUDITH CHERYL UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $108,416 No NIH Category available.
CANCER CENTER CORE SUPPORT GRANT 3P30CA016042-33S3 1977-12-01 2006-12-01 1-Apr-09 2007 GASSON, JUDITH CHERYL UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $113,053 No NIH Category available.
CANCER CENTER CORE SUPPORT GRANT 3P30CA016042-33S6 1977-12-01 2006-12-01 1-Apr-09 2008 GASSON, JUDITH CHERYL UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $113,837 Biotechnology;Cancer;Clinical Research;Clinical Trials;Urologic Diseases
CANCER CENTER CORE SUPPORT GRANT 5P30CA016042-33 1977-12-01 2006-12-01 1-Apr-09 2007 GASSON, JUDITH CHERYL UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $4,541,766 No NIH Category available.
TARGETED ALPHA-PARTICLE EMITTER THERAPY OF METASTASES 5R01CA113797-02 2005-12-09 2006-12-01 30-Nov-07 2007 SGOUROS, GEORGE JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NCI $278,181 No NIH Category available.
LCCC 0310 DENDRITIC CELL VACCINE GIVEN WITH TRASTUZUMAB AND VINORELBINE 5M01RR000046-47 2006-12-01 2006-12-01 30-Nov-07 2007 SERODY, JONATHAN STUART UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCRR $5,252 No NIH Category available.
IMMUNOTHERAPY FOR GLIOMAS WITH MONOCLONAL ANTIBODIES TARGETING MCSP 5R21NS054167-02 2006-01-01 2006-12-31 30-Dec-08 2007 FENSTERMAKER, ROBERT A ROSWELL PARK CANCER INSTITUTE CORP BUFFALO NY UNITED STATES NINDS $230,024 No NIH Category available.
NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT 5U10CA012027-37 1976-12-01 2007-02-01 31-Jan-08 2007 WOLMARK, NORMAN NSABP FOUNDATION, INC. PITTSBURGH PA UNITED STATES NCI $8,403,989 No NIH Category available.
ERBB2 TARGETED ANTITUMOR STRATEGIES IN BREAST CANCER 5R01CA080195-09 1999-01-01 2007-02-01 31-Jan-09 2007 ARTEAGA, CARLOS L VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $302,816 No NIH Category available.
ERBB RECEPTOR HOMO-AND HETERO-DIMERIZATION 5R01CA079992-09 1999-02-01 2007-02-01 31-Jan-08 2007 LEMMON, MARK A. UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA UNITED STATES NCI $242,246 No NIH Category available.
PHARMACODYNAMIC ASSESSMENT OF RTK INHIBITORS IN CANCER 5R01CA112385-03 2005-02-23 2007-02-01 31-Jan-08 2007 HALLAHAN, DENNIS E VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $258,357 No NIH Category available.
NSABP PARTICIPATING SITES 5U10CA118735-02 2006-04-10 2007-02-01 31-Jan-08 2007 CHANG, JENNY C-N BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $66,456 No NIH Category available.
MODELING CELL RECEPTOR SIGNALING PATHWAYS 5R01GM072821-03 2005-03-01 2007-03-01 31-Jul-08 2007 RESAT, HALUK BATTELLE PACIFIC NORTHWEST LABORATORIES RICHLAND WA UNITED STATES NIGMS $275,798 No NIH Category available.
BRAIN TUMORS - IMMUNOLOGICAL AND BIOLOGICAL STUDIES 5R37CA011898-37 1976-12-01 2007-04-01 31-Mar-08 2007 BIGNER, DARELL D DUKE UNIVERSITY DURHAM NC UNITED STATES NCI $642,571 No NIH Category available.
SPECTROSCOPIC LOCALIZATION OF BREAST CANCER 5R44CA083597-05 1999-08-13 2007-04-01 31-Mar-08 2007 BENARON, DAVID A. SPECTROS CORPORATION Portola Valley CA UNITED STATES NCI $995,474 No NIH Category available.
REGULATION OF ERBB2/NEU-INDUCED MAMMARY GLAND CANCER 2R01CA090398-06A1 2001-03-05 2007-04-01 31-Jan-08 2007 KERI, RUTH A CASE WESTERN RESERVE UNIVERSITY CLEVELAND OH UNITED STATES NCI $216,920 No NIH Category available.
ROLE OF NEUREGULIN/ERBB SIGNALING IN THE ADULT HEART 5R01HL068144-07 2001-09-30 2007-04-01 31-Mar-08 2007 SAWYER, DOUGLAS B VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NHLBI $327,212 No NIH Category available.
PHASE II STUDY OF A HER-2/NEU INTRACELLULAR DOMAIN (ICD) PEPTIDE-BASED VACCINE 5M01RR000037-47 2007-04-01 2007-04-01 16-Sep-07 2007 DISIS, MARY L. UNIVERSITY OF WASHINGTON SEATTLE WA UNITED STATES NCRR $609 No NIH Category available.
NSABP B-31 5M01RR006192-14 2007-04-01 2007-04-01 31-Mar-08 2007 KURTZMAN, SCOTT UNIVERSITY OF CONNECTICUT SCH OF MED/DNT FARMINGTON CT UNITED STATES NCRR $784 No NIH Category available.
PHASE I-II STUDY OF COMBINATION IMMUNOTHERAPY FOR HER-2/NEU CYTOTOXIC T CELLS 5M01RR000037-47 2007-04-01 2007-04-01 16-Sep-07 2007 DISIS, MARY L. UNIVERSITY OF WASHINGTON SEATTLE WA UNITED STATES NCRR $2,053 No NIH Category available.
P III TRIAL OF DOXORUBICIN & CYCLOPHOSPHAMIDE FOL BY WEEKLY PACLITAXEL W/WO TRAS 5M01RR010732-13 2007-04-01 2007-04-01 31-Mar-08 2007 RYBKA, WITOLD B. PENNSYLVANIA STATE UNIV HERSHEY MED CTR HERSHEY PA UNITED STATES NCRR $3,267 No NIH Category available.
P III TRIAL OF DOXORUBICIN & CYCLOPHOSPHAMIDE FOL BY WEEKLY PACLITAXEL W/WO TRAS 5M01RR010732-13 2007-04-01 2007-04-01 31-Mar-08 2007 RYBKA, WITOLD B. PENNSYLVANIA STATE UNIV HERSHEY MED CTR HERSHEY PA UNITED STATES NCRR $5,083 No NIH Category available.
BI-WEEKLY TAXOL & RT IN ANDROGEN ABLATED ADVANCED PROSTATE CANCER 5M01RR000096-46 2007-04-01 2007-04-01 31-Mar-08 2007 FORMENTI, SILVIA C NEW YORK UNIVERSITY SCHOOL OF MEDICINE NEW YORK NY UNITED STATES NCRR $10,258 No NIH Category available.
INDIVIDUALIZED TX OF BREAST CANCER BASED ON TUMOR MOLECULAR CHARACTERISTICS 5M01RR000096-46 2007-04-01 2007-04-01 31-Mar-08 2007 FORMENTI, SILVIA C NEW YORK UNIVERSITY SCHOOL OF MEDICINE NEW YORK NY UNITED STATES NCRR $61,938 No NIH Category available.
MODULATION BY BOTANICALS OF ANTIBODY BASED CANCER IMMUNOTHERAPY 5P50AT002779-03 2007-04-01 31-Mar-08 2007 CHEUNG, NAI-KONG V SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCCAM $283,563 No NIH Category available.
NEXT GENERATION STRATEGIES TO INTERCEPT ERBB SIGNALING 5R37CA072981-11 1997-04-25 2007-04-04 31-Mar-08 2007 YARDEN, YOSEF NONE WEIZMANN INSTITUTE OF SCIENCE REHOVOT ISRAEL NCI $230,408 No NIH Category available.
NORTH CENTRAL CANCER TREATMENT GROUP 3U10CA025224-28S1 1982-01-01 2007-04-20 31-Dec-07 2007 BUCKNER, JAN C MAYO CLINIC ROCHESTER MN UNITED STATES NCI $222,000 No NIH Category available.
NORTH CENTRAL CANCER TREATMENT GROUP 3U10CA025224-28S2 1982-01-01 2007-04-20 31-Dec-07 2007 BUCKNER, JAN C MAYO CLINIC ROCHESTER MN UNITED STATES NCI $300,000 No NIH Category available.
NORTH CENTRAL CANCER TREATMENT GROUP 3U10CA025224-28S3 1982-01-01 2007-04-20 31-Dec-07 2007 BUCKNER, JAN C MAYO CLINIC ROCHESTER MN UNITED STATES NCI $2,543,699 No NIH Category available.
GROWTH FACTOR RECEPTOR SIGNALING IN BREAST CANCER 5P01CA099031-05 2003-04-01 2007-04-20 31-Mar-10 2007 HUNG, MIEN-CHIE UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $1,131,894 No NIH Category available.
TARGETING JAB1 ONCOGENIC FUNCTION IN BREAST CANCER 2R01CA090853-06 2001-04-01 2007-04-25 31-Jan-08 2007 CLARET, FRANCOIS X UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $255,009 No NIH Category available.
EASTERN COOPERATIVE ONCOLOGY GROUP 5U10CA016116-34 1978-06-01 2007-05-01 30-Apr-08 2007 FORASTIERE, ARLENE ANN JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NCI $279,594 No NIH Category available.
HER2 PATHWAY IN BREAST CANCER PROGRESSION AND TREATMENT 5R01CA065746-13 1995-02-01 2007-05-01 30-Apr-08 2007 KUMAR, RAKESH UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $250,558 No NIH Category available.
MOLECULAR STUDIES OF ESOPHAGEAL ADENOCARCINOMA 5R01CA071606-11 1997-06-05 2007-05-01 30-Apr-08 2007 BEER, DAVID GEORGE UNIVERSITY OF MICHIGAN AT ANN ARBOR ANN ARBOR MI UNITED STATES NCI $305,949 No NIH Category available.
BREAST CANCER RESPONSE MARKERS TO A DUAL HER1/2 BLOCKER 5R01CA112305-03 2005-06-16 2007-05-01 30-Apr-08 2007 CHANG, JENNY C-N BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $252,236 No NIH Category available.
FUNCTIONS IN TUMORS OF RECURRENTLY AMPLIFIED PREFOLDIN-4 5R01CA112608-03 2005-07-25 2007-05-01 30-Apr-08 2007 HANAHAN, DOUGLAS UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $283,709 No NIH Category available.
METABOLIC PHENOTYPING WITH PET TO MONITOR AND PREDICT RESPONSE TO KINASE 5P50CA086306-08 2007-05-01 30-Apr-08 2007 CZERNIN, JOHANNES UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $258,182 No NIH Category available.
IMPROVING INTERSTITIAL TRANSPORT IN TUMORS 5P01CA080124-07 2007-05-01 30-Apr-08 2007 JAIN, RAKESH K. MASSACHUSETTS GENERAL HOSPITAL BOSTON MA UNITED STATES NCI $309,412 No NIH Category available.
FUNCTION OF MUC4 IN MAMMARY EPITHELIA AND TUMORS 5R01CA052498-15 1991-09-30 2007-06-01 31-May-08 2007 CARRAWAY, KERMIT L. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE MIAMI FL UNITED STATES NCI $262,065 No NIH Category available.
DEVELOPMENT OF ERBB2 BASED BREAST CANCER VACCINES 5R01CA076340-10 1997-12-04 2007-06-01 31-May-10 2007 WEI, WEI-ZEN WAYNE STATE UNIVERSITY DETROIT MI UNITED STATES NCI $269,170 No NIH Category available.
TARGETED INTERVENTION OF BREAST ONCOGENIC PATHWAYS 3R01CA098473-05S1 2003-06-13 2007-06-01 31-May-08 2007 SEBTI, SAID M H. LEE MOFFITT CANCER CTR & RES INST TAMPA FL UNITED STATES NCI $121,464 No NIH Category available.
PROFILING EGFR AND HER2 IN BREAST CANCER USING MULTIPLEX TISSUE IMMUNOSTAINING 1R43CA123994-01A2 2007-06-15 2007-06-15 30-Nov-07 2007 JAMES, WILLIAM M 20/20 GENESYSTEMS, INC. ROCKVILLE MD UNITED STATES NCI $117,930 No NIH Category available.
PAUL CALABRESI PROGRAM IN CLINICAL-TRANSLATIONAL RESEARCH AT MAYO CLINIC 5K12CA090628-07 2001-09-25 2007-07-01 30-Jun-08 2007 HARTMANN, LYNN C. MAYO CLINIC ROCHESTER MN UNITED STATES NCI $665,657 No NIH Category available.
ANTIBODY MICROARRAYS FOR CANCER DIAGNOSTICS 5R44CA105540-03 2004-03-01 2007-07-01 31-Dec-08 2007 NIELSEN, ULRIK B. MERRIMACK PHARMACEUTICALS, INC. CAMBRIDGE MA UNITED STATES NCI $386,520 No NIH Category available.
GROWTH FACTOR AS ANTI-ANGIOGENESIS AGENTS 5R01CA106829-04 2004-09-30 2007-07-01 30-Jun-08 2007 SEBTI, SAID M H. LEE MOFFITT CANCER CTR & RES INST TAMPA FL UNITED STATES NCI $321,936 No NIH Category available.
IN VIVO THERMOACOUSTIC IMAGING OF HER2 STATUS 5R44CA114839-03 2005-04-07 2007-07-01 30-Jun-08 2007 KRUGER, ROBERT A OPTOSONICS, INC. ORIENTAL NC UNITED STATES NCI $815,842 No NIH Category available.
IDENTIFICATION AND CHARACTERIZATION OF ACTIVATED TYROSINE KINASES IN GLIOBLASTOMA 1F32CA121769-01A1 2007-07-01 2007-07-01 30-Jun-08 2007 STOMMEL, JAYNE DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $52,898 No NIH Category available.
MECHANISMS OF INVERTEBRATE EGF RECEPTOR INHIBITION 1R01CA125432-01A1 2007-07-01 2007-07-01 31-May-08 2007 LEMMON, MARK A. UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA UNITED STATES NCI $236,888 No NIH Category available.
CLINICAL PRODUCTION 2P01CA043904-16A1 2007-07-01 2007-07-01 30-Jun-08 2007 YAZAKI, PAUL CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $296,825 No NIH Category available.
MOLECULAR TARGETS FOR PROGNOSIS AND THERAPY 5P50CA083636-09 2007-07-01 30-Jun-08 2007 HOOD, LEROY E FRED HUTCHINSON CANCER RESEARCH CENTER SEATTLE WA UNITED STATES NCI $548,026 No NIH Category available.
ANALYSIS OF CIRCULATING TUMOR CELLS IN A PHASE I/II STUDY FOR BREAST CANCER 5R21CA121541-02 2006-07-07 2007-07-05 30-Jun-10 2007 SWABY, RAMONA F FOX CHASE CANCER CENTER PHILADELPHIA PA UNITED STATES NCI $307,278 No NIH Category available.
FATTY ACID SYNTHASE:MOLECULAR TARGET FOR BREAST CANCER THERAPY & CHEMOPREVENTION 5R01CA116623-03 2005-09-16 2007-07-24 31-May-08 2007 LUPU, RUTH NORTHSHORE UNIV HEALTHSYSTEM RES INST EVANSTON IL UNITED STATES NCI $418,872 No NIH Category available.
CROSSTALK TGFBETA AND HER2 (ERBB2) SIGNALING IN MAMMARY TUMORIGENESIS 1K99CA125892-01 2007-07-25 2007-07-25 30-Jun-08 2007 WANG, SHIZHEN EMILY VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $117,905 No NIH Category available.
THE AGING GUT: REGULATION OF CELL PROLIFERATION 2R01AG014343-10A1 1997-09-01 2007-08-01 31-Jul-08 2007 MAJUMDAR, ADHIP N. WAYNE STATE UNIVERSITY DETROIT MI UNITED STATES NIA $232,470 No NIH Category available.
STRUCTURAL STUDIES OF GROWTH FACTOR RECEPTOR FUNCTION 5R01CA090466-06 2001-04-01 2007-08-01 31-Jul-08 2007 LEAHY, DANIEL J JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NCI $222,384 No NIH Category available.
MICELLE SURFACE ENGINEERING FOR ACTIVE TARGETING BY ACIDIC TUMOR EXTRACELLULAR PH 5R01CA122356-02 2006-08-22 2007-08-01 31-Jul-08 2007 BAE, YOU HAN UNIVERSITY OF UTAH SALT LAKE CITY UT UNITED STATES NCI $257,668 No NIH Category available.
NEW BIFUNCTIONAL LIGANDS FOR RADIOIMMUNOTHERAPY 5R01CA112503-02 2006-09-01 2007-08-01 31-Jul-08 2007 CHONG, HYUN-SOON ILLINOIS INSTITUTE OF TECHNOLOGY CHICAGO IL UNITED STATES NCI $138,368 No NIH Category available.
OPENING THE BLOOD BRAIN BARRIER FOR MOLECULAR IMAGING 5U41RR019703-03 2007-08-01 2007-08-01 31-Jul-08 2007 HYNYNEN, KULLERVO BRIGHAM AND WOMEN'S HOSPITAL BOSTON MA UNITED STATES NCRR $12,196 No NIH Category available.
ERBB2 DOWNREGULATION THROUGH HSP90 INHIBITION 1R01CA116552-01A2 2007-08-01 2007-08-01 31-Oct-07 2007 BAND, HAMID NORTHSHORE UNIV HEALTHSYSTEM RES INST EVANSTON IL UNITED STATES NCI $49,190 No NIH Category available.
DEVELOPMENT OF AN EFC ASSAY TO MEASURE GROWTH FACTOR RECEPTOR DIMER FORMATION FOR 1R43CA130236-01 2007-08-01 2007-08-01 30-Apr-08 2007 OLSON, KEITH DISCOVERX CORPORATION FREMONT CA UNITED STATES NCI $113,104 No NIH Category available.
BREAST CANCER VACCINE STRATEGIES FOR HER2-OVEREXPRESSING AND LUM. B TUMORS 5P50CA058223-15 2007-08-01 31-Jul-08 2007 SERODY, JONATHAN STUART UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCI $218,703 No NIH Category available.
WUMC-CANCER AND LEUKEMIA GROUP B 5U10CA077440-10 1998-05-08 2007-08-03 31-Mar-08 2007 BARTLETT, NANCY L WASHINGTON UNIVERSITY SAINT LOUIS MO UNITED STATES NCI $334,381 No NIH Category available.
RESEARCH PROGRAMS-SIGNAL TRANSDUCTION 2P30CA016359-29 2007-08-09 2007-08-09 31-Jul-08 2007 SCHLESSINGER, JOSEPH YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $19,358 No NIH Category available.
RADIOIMMUNOTHERAPY: CLINICAL STUDIES 2P01CA043904-16A1 2007-07-01 2007-08-13 30-Jun-08 2007 WONG, JEFFREY Y CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $230,528 No NIH Category available.
RADIOPHARMACY AND ASSAYS 2P01CA043904-16A1 2007-07-01 2007-08-13 30-Jun-08 2007 COLCHER, DAVID MORRIS CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $472,615 No NIH Category available.
NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT 3U10CA012027-37S1 1976-12-01 2007-08-20 31-Jan-08 2007 WOLMARK, NORMAN NSABP FOUNDATION, INC. PITTSBURGH PA UNITED STATES NCI $450,000 No NIH Category available.
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 3P50CA089393-08S1 2000-09-30 2007-09-01 31-Aug-08 2007 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $412,443 No NIH Category available.
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 5P50CA089393-08 2000-09-30 2007-09-01 31-Aug-08 2007 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $2,180,817 No NIH Category available.
MODIFIED HER-2 TUMOR ANTIGENS FOR VACCINATION IN CANCER 5R42CA106107-03 2004-03-01 2007-09-01 31-Aug-10 2007 MAMULA, MARK J. L2 DIAGNOSTICS, LLC NEW HAVEN CT UNITED STATES NCI $574,787 No NIH Category available.
DISCOVERY AND CHARACTERIZATION OF BREAST CANCER GENES 5K01CA101777-04 2004-09-07 2007-09-01 31-Aug-08 2007 HODGSON, JOHN G UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $148,770 No NIH Category available.
BLOOD TEST DETECTS CHANGE FROM HER2- TO + IN BREAST CANCER 5R01CA101790-03 2005-09-01 2007-09-01 31-Aug-08 2007 UHR, JONATHAN W UNIVERSITY OF TEXAS SW MED CTR/DALLAS DALLAS TX UNITED STATES NCI $253,070 No NIH Category available.
UTMDACC SPORE IN BREAST CANCER 5P50CA116199-03 2005-09-23 2007-09-01 31-Aug-08 2007 HORTOBAGYI, GABRIEL N UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $2,180,817 No NIH Category available.
LIPOSOMAL DELIVERY OF HIGH LET EMITTERS TO CELL NUCLEI 5F32CA123651-02 2006-09-01 2007-09-01 31-Aug-08 2007 HAR-EL, YAH-EL JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NCI $48,796 No NIH Category available.
CHARACTERIZATION OF METHODS FOR PRESERVATION OF PHOSPHOPROTEINS IN FIXED TISSUES 5R21CA123006-02 2006-09-01 2007-09-01 31-Aug-08 2007 HSI, ERIC CLEVELAND CLINIC LERNER COL/MED-CWRU CLEVELAND OH UNITED STATES NCI $168,773 No NIH Category available.
VALIDATION AND QUANTIFICATION OF FFPE ANTIGEN RETRIEVAL BY PROTEOME ANALYSIS 5R41CA122715-02 2006-09-01 2007-09-01 31-Aug-08 2007 SAXENA, SATYA PRAKASH CALIBRANT BIOSYSTEMS, INC. Gaithersburg MD UNITED STATES NCI $219,582 No NIH Category available.
MOUSE MODELING AND ANIMAL DEVELOPMENT 2P01CA095426-06 2007-09-01 2007-09-01 31-Aug-08 2007 MUTHUSAMY, NATARAJAN OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $223,606 No NIH Category available.
P-2: TARGET COMBINATIONS FOR HER2 - POSITIVE BREAST CANCER 5P50CA089393-08 2007-09-01 31-Aug-08 2007 HARRIS, LYNDSAY N DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $133,233 No NIH Category available.
HSP90 AS A TARGET FOR MECHANISM-BASED THERAPY FOR CASTRATION-RESISTANT PROSTATE C 5P50CA092629-07 2007-09-01 31-Aug-08 2007 ROSEN, NEAL SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $413,330 No NIH Category available.
COMBINATORIAL LIBRARY SCREENING CORE 5U54CA119343-03 2007-09-01 31-Aug-08 2007 LIU, RIHE UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCI $425,854 No NIH Category available.
IMPROVING THE PHARMACOKINETICS OF A NEW PROTEIN-BASED PAN-HER ANTAGONIST. 1R43CA130378-01 2007-09-10 2007-09-10 9-Mar-08 2007 MONTICELLO, DANIEL J MOLECULAR LOGIX, INC. THE WOODLANDS TX UNITED STATES NCI $136,332 No NIH Category available.
NOVEL TARGETED THERAPY FOR BREAST CANCER 1R43CA124179-01A1 2007-09-11 2007-09-11 29-Feb-08 2007 SERRERO, GINETTE A AND G PHARMACEUTICAL, INC. COLUMBIA MD UNITED STATES NCI $120,600 No NIH Category available.
ESTROGEN RECEPTOR PHOSPHORYLATION AND PROMOTER RECRUITMENT IN BREAST CANCER. 5F31CA126489-02 2006-09-14 2007-09-14 13-Sep-08 2007 DUPLESSIS, TAMIKA T TULANE UNIVERSITY OF LOUISIANA NEW ORLEANS LA UNITED STATES NCI $28,120 No NIH Category available.
REGULATION OF HER2/NEU BY ACTIVATION LOOP PHOSPHORYLATION AND ALG-2 1K22CA128951-01 2007-09-18 2007-09-18 31-Aug-08 2007 BOSE, RON WASHINGTON UNIVERSITY SAINT LOUIS MO UNITED STATES NCI $143,183 No NIH Category available.
MECHANISM OF ACTION OF DIFFERENTIATION AGENTS 7R37CA038173-22 1986-07-01 2007-09-20 30-Jun-08 2007 BRATTAIN, MICHAEL G. UNIVERSITY OF NEBRASKA MEDICAL CENTER OMAHA NE UNITED STATES NCI $321,158 No NIH Category available.
NOVEL PLATFORM TECHNOLOGY FOR DEVELOPING THERAPEUTIC HUMAN MABS 1R43CA126070-01A1 2007-09-21 2007-09-21 30-Nov-08 2007 KRAVITZ, RACHEL HANNAH NEOCLONE BIOTECHNOLOGY INTERNATIONAL MADISON WI UNITED STATES NCI $140,000 No NIH Category available.
EVALUATION OF NOVEL CYTOTOXIC COMPOUNDS FOR IMMUNOCONJUGATES 1R43CA128322-01 2007-09-21 2007-09-21 31-Aug-08 2007 BELL, STANLEY C ONCONOVA THERAPEUTICS, INC. NEWTOWN PA UNITED STATES NCI $155,103 No NIH Category available.
INNATE IMMUNITY: ELUCIDATION AND MODULATION FOR CANCER THERAPY 2P01CA095426-06 2002-02-01 2007-09-24 31-Aug-08 2007 CALIGIURI, MICHAEL A OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $1,987,279 No NIH Category available.
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21 2P01CA095426-06 2007-09-01 2007-09-24 31-Aug-08 2007 CARSON, WILLIAM E. OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $392,148 No NIH Category available.
REWIRING ERBB SIGNALING IN CANCER CELLS 2R01CA098881-05A1 2003-07-01 2007-09-25 31-Jul-08 2007 LANDGRAF, RALF UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $273,042 No NIH Category available.
UTMDACC SPORE IN BREAST CANCER 3P50CA116199-03S1 2005-09-23 2007-09-25 31-Aug-08 2007 HORTOBAGYI, GABRIEL N UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $398,581 No NIH Category available.
EARLY SCREENING OF BREAST LESION TRIAL (PHASE III PIVOTAL) 1R44CA126441-01 2007-09-27 2007-09-27 28-Feb-08 2007 BENARON, DAVID A. SPECTROS CORPORATION Portola Valley CA UNITED STATES NCI $222,084 No NIH Category available.
PROCESSING AC-227 SOURCES FOR LEAD-212 AND RADIUM-223 REQUIRED BY CANCER RESEARCH 1R41CA124302-01A1 2007-09-28 2007-09-28 31-Aug-09 2007 SODERQUIST, CHUCK Z ALPHAMED, INC Wrentham MA UNITED STATES NCI $111,300 No NIH Category available.
CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING 1R44CA130026-01 2007-09-28 2007-09-28 31-Jan-09 2007 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION WOBURN MA UNITED STATES NCI $227,868 No NIH Category available.
A NOVEL TRANSGENIC SILKWORM SYSTEM FOR RECOMBINANT GLYCOPROTEIN PRODUCTION 1R01GM080672-01A1 2007-09-29 2007-09-29 31-Jul-08 2007 JARVIS, DONALD L. UNIVERSITY OF WYOMING LARAMIE WY UNITED STATES NIGMS $299,250 No NIH Category available.
TARGETED ALPHA-PARTICLE EMITTER THERAPY OF METASTASES 5R01CA113797-03 2005-12-09 2007-12-01 30-Nov-08 2008 SGOUROS, GEORGE JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NCI $278,677 Breast Cancer;Cancer;Digestive Diseases;Liver Disease
TARGETING THE HER2 PATHWAY: MECHANISMS OF RESISTANCE & STRATEGIES TO OVERCOME 2P50CA058183-14 2007-12-01 2007-12-01 30-Nov-08 2008 OSBORNE, C KENT BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $161,961 Breast Cancer;Cancer;Infectious Diseases
NOVEL TREATMENT OF NF-1 ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS 1R01CA122804-01A2 2007-12-07 2007-12-07 30-Nov-08 2008 CARROLL, STEVEN L UNIVERSITY OF ALABAMA AT BIRMINGHAM BIRMINGHAM AL UNITED STATES NCI $300,875 Biotechnology;Cancer;Neurofibromatosis;Neurosciences
MODIFIERS OF TUMOR SUSCEPTIBILITY IN MURINE NEUROBLASTOMA 3R01NS055750-01A2S1 2007-12-15 2007-12-15 30-Nov-08 2008 WEISS, WILLIAM A UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NINDS $35,000 Biotechnology;Cancer;Genetics;Human Genome;Neurosciences;Pediatric
MODIFIERS OF TUMOR SUSCEPTIBILITY IN MURINE NEUROBLASTOMA 1R01NS055750-01A2 2007-12-15 2007-12-15 30-Nov-08 2008 WEISS, WILLIAM A UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NINDS $337,331 Biotechnology;Cancer;Genetics;Human Genome;Neurosciences;Pediatric
TRANSLATIONAL RESEARCH IN BREAST CANCER 2P50CA058183-14 1992-09-30 2007-12-28 30-Nov-08 2008 OSBORNE, C KENT BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $2,300,000 No NIH Category available.
NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT 3U10CA012027-38S1 1976-12-01 2008-02-01 31-Jan-09 2008 WOLMARK, NORMAN NSABP FOUNDATION, INC. PITTSBURGH PA UNITED STATES NCI $236,163 No NIH Category available.
NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT 5U10CA012027-38 1976-12-01 2008-02-01 31-Jan-09 2008 WOLMARK, NORMAN NSABP FOUNDATION, INC. PITTSBURGH PA UNITED STATES NCI $7,116,748 No NIH Category available.
NSABP PARTICIPATING SITES 5U10CA118735-03 2006-04-10 2008-02-01 31-Jan-09 2008 CHANG, JENNY C-N BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $66,231 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials
REGULATION OF STAT3 SIGNALING 5R01CA122910-02 2007-04-01 2008-02-01 31-Jan-09 2008 REICH, NANCY C. STATE UNIVERSITY NEW YORK STONY BROOK STONY BROOK NY UNITED STATES NCI $294,500 Cancer;Genetics;Hematology
TARGETING JAB1 ONCOGENIC FUNCTION IN BREAST CANCER 5R01CA090853-07 2001-04-01 2008-02-21 31-Jan-09 2008 CLARET, FRANCOIS X UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $255,009 Biotechnology;Breast Cancer;Cancer;Genetics
REGULATION OF ERBB2/NEU-INDUCED MAMMARY GLAND CANCER 5R01CA090398-07 2001-03-05 2008-02-25 31-Jan-09 2008 KERI, RUTH A CASE WESTERN RESERVE UNIVERSITY CLEVELAND OH UNITED STATES NCI $212,114 Breast Cancer;Cancer;Genetics
ERBB2 DOWNREGULATION THROUGH HSP90 INHIBITION 7R01CA116552-02 2007-08-01 2008-02-26 31-May-08 2007 BAND, HAMID UNIVERSITY OF NEBRASKA MEDICAL CENTER OMAHA NE UNITED STATES NCI $239,610 No NIH Category available.
REGULATION OF ERBB2/NEU-INDUCED MAMMARY GLAND CANCER 3R01CA090398-07S1 2001-03-05 2008-03-01 31-Jan-09 2008 KERI, RUTH A CASE WESTERN RESERVE UNIVERSITY CLEVELAND OH UNITED STATES NCI $77,462 Breast Cancer;Cancer;Genetics
GENERATION OF A THERAPEUTIC ANTIBODY DIRECTED AGAINST CCR4 FOR PATIENTS WITH 2P50CA093683-06A2 2008-03-01 2008-03-01 31-Jul-09 2008 MARASCO, WAYNE A. BRIGHAM AND WOMEN'S HOSPITAL BOSTON MA UNITED STATES NCI $216,958 Biotechnology;Cancer;Immunization;Lymphoma;Prevention;Vaccine Related
NEXT GENERATION STRATEGIES TO INTERCEPT ERBB SIGNALING 5R37CA072981-12 1997-04-25 2008-04-01 31-Mar-09 2008 YARDEN, YOSEF NONE WEIZMANN INSTITUTE OF SCIENCE REHOVOT ISRAEL NCI $230,408 Biotechnology;Cancer;Prevention
WUMC-CANCER AND LEUKEMIA GROUP B 5U10CA077440-11 1998-05-08 2008-04-01 31-Mar-09 2008 BARTLETT, NANCY L WASHINGTON UNIVERSITY SAINT LOUIS MO UNITED STATES NCI $334,932 Breast Cancer;Cancer;Clinical Research;Clinical Trials;Colo-Rectal Cancer;Diagnostic Radiology;Digestive Diseases;Genetics;Hematology;Lung;Lung Cancer;Lymphoma;Orphan Drug;Prostate Cancer;Stem Cell Research;Stem Cell Research - Nonembryonic - Human;Transplantation;Urologic Diseases
THE ROLE OF SYNDECAN-1 IN MOUSE MAMMARY NEOPLASIA 2R01CA090877-06A2 2001-04-01 2008-04-01 31-Jan-09 2008 ALEXANDER, CAROLINE MARGARET UNIVERSITY OF WISCONSIN MADISON MADISON WI UNITED STATES NCI $295,173 Breast Cancer;Cancer;Stem Cell Research;Stem Cell Research - Nonembryonic - Non-Human
ROLE OF NEUREGULIN/ERBB SIGNALING IN THE ADULT HEART 5R01HL068144-08 2001-09-30 2008-04-01 31-Mar-09 2008 SAWYER, DOUGLAS B VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NHLBI $327,478 Cardiovascular;Heart Disease
CLINICAL TRIAL: P III TRIAL OF DOXORUBICIN & CYCLOPHOSPHAMIDE FOL BY WEEKLY PACL 5M01RR010732-14 2008-04-01 2008-04-01 31-Mar-09 2008 RYBKA, WITOLD B. PENNSYLVANIA STATE UNIV HERSHEY MED CTR HERSHEY PA UNITED STATES NCRR $1,217 Breast Cancer;Cancer;Clinical Research;Clinical Trials
CLINICAL TRIAL: INDIVIDUALIZED TX OF BREAST CANCER BASED ON TUMOR MOLECULAR CHAR 5M01RR000096-47 2008-04-01 2008-04-01 31-Mar-09 2008 FORMENTI, SILVIA C NEW YORK UNIVERSITY SCHOOL OF MEDICINE NEW YORK NY UNITED STATES NCRR $2,166 Breast Cancer;Cancer;Clinical Research;Clinical Trials;Orphan Drug
CLINICAL TRIAL: P III TRIAL OF DOXORUBICIN & CYCLOPHOSPHAMIDE FOL BY WEEKLY PACL 5M01RR010732-14 2008-04-01 2008-04-01 31-Mar-09 2008 RYBKA, WITOLD B. PENNSYLVANIA STATE UNIV HERSHEY MED CTR HERSHEY PA UNITED STATES NCRR $6,491 Breast Cancer;Cancer;Clinical Research;Clinical Trials
STRUCTURE-BASED PREDICTION OF THE INTERACTOME 1R01GM081871-01A1 2008-04-01 2008-04-01 31-Mar-09 2008 BERGER, BONNIE MASSACHUSETTS INSTITUTE OF TECHNOLOGY CAMBRIDGE MA UNITED STATES NIGMS $280,891 Bioengineering;Biotechnology;Genetics;Human Genome;Networking and Information Technology R&D
ROLES OF NF-KB/REL IN THE PATHOGENESIS OF BREAST CANCER 1R01CA129129-01A1 2008-04-01 2008-04-01 31-Jan-09 2008 SONENSHEIN, GAIL E BOSTON UNIVERSITY MEDICAL CAMPUS BOSTON MA UNITED STATES NCI $337,188 Breast Cancer;Cancer;Complementary and Alternative Medicine;Genetics;Nutrition
DEVELOPMENT OF MECHANISM-BASED STRATEGIES FOR THE TREATMENT OF ADVANCED BREAST CA 2P01CA094060-06A1 2008-04-01 2008-04-01 30-Apr-09 2008 ROSEN, NEAL SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $435,045 Breast Cancer;Cancer;Clinical Research
PREDICTION OF NEOADJUVANT CHEMO PATHOLOGICAL RESPONSE USING MRI MARKERS 1R01CA127927-01A1 2008-04-01 2008-04-01 31-Jan-09 2008 SU, MIN-YING L UNIVERSITY OF CALIFORNIA IRVINE IRVINE CA UNITED STATES NCI $488,611 Breast Cancer;Cancer;Clinical Research;Diagnostic Radiology;Orphan Drug
MODULATION BY BOTANICALS OF ANTIBODY BASED CANCER IMMUNOTHERAPY 5P50AT002779-04 2008-04-01 31-Mar-09 2008 CHEUNG, NAI-KONG V SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCCAM $145,273 Biotechnology;Cancer;Complementary and Alternative Medicine;Immunization;Prevention;Vaccine Related
MECHANISMS OF TUMOR RESISTANCE TO ANTI-HER/ERBB THERAPEUTICS 1R01CA129036-01A1 2008-04-02 2008-04-02 31-Jan-09 2008 FAN, ZHEN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $319,550 Biotechnology;Breast Cancer;Cancer;Hematology
TARGETING THE IGF SYSTEM IN BREAST CANCER 2R01CA074285-11A1 1998-01-01 2008-04-10 31-Mar-09 2008 YEE, DOUGLAS UNIVERSITY OF MINNESOTA TWIN CITIES MINNEAPOLIS MN UNITED STATES NCI $354,219 Breast Cancer;Cancer
EASTERN COOPERATIVE ONCOLOGY GROUP 5U10CA016116-35 1978-06-01 2008-05-01 30-Apr-09 2008 FORASTIERE, ARLENE ANN JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NCI $279,595 Biotechnology;Brain Cancer;Brain Disorders;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Dental/Oral and Craniofacial Disease;Digestive Diseases;Genetics;Hematology;Immunization;Lung;Lung Cancer;Lymphoma;Neurosciences;Orphan Drug;Prevention;Prostate Cancer;Stem Cell Research;Stem Cell Research - Nonembryonic - Human;Transplantation;Urologic Diseases;Vaccine Related
MOLECULAR STUDIES OF ESOPHAGEAL ADENOCARCINOMA 5R01CA071606-12 1997-06-05 2008-05-01 30-Apr-09 2008 BEER, DAVID GEORGE UNIVERSITY OF MICHIGAN AT ANN ARBOR ANN ARBOR MI UNITED STATES NCI $305,939 Biotechnology;Cancer;Clinical Research;Digestive Diseases;Genetics
BREAST CANCER RESPONSE MARKERS TO A DUAL HER1/2 BLOCKER 5R01CA112305-04 2005-06-16 2008-05-01 30-Apr-09 2008 CHANG, JENNY C-N BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $252,236 Breast Cancer;Cancer;Clinical Research;Genetics
FUNCTIONS IN TUMORS OF RECURRENTLY AMPLIFIED PREFOLDIN-4 5R01CA112608-04 2005-07-25 2008-05-01 30-Apr-09 2008 HANAHAN, DOUGLAS UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $283,709 Biotechnology;Breast Cancer;Cancer;Genetics
TARGETING HER-2 PROTEIN FOR BREAST CANCER USING COMPUTATIONAL APPROACH 5P20RR016456-07 2008-05-01 2008-05-01 30-Apr-09 2008 SATYANARAYANAJOIS, SEETHARAMA D LOUISIANA STATE UNIV A&M COL BATON ROUGE BATON ROUGE LA UNITED STATES NCRR $62,058 Breast Cancer;Cancer;Lung;Lung Cancer
METABOLIC PHENOTYPING WITH PET TO MONITOR AND PREDICT RESPONSE TO KINASE 5P50CA086306-09 2008-05-01 30-Apr-09 2008 CZERNIN, JOHANNES UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $258,131 Bioengineering;Brain Cancer;Brain Disorders;Cancer;Clinical Research;Diagnostic Radiology;Genetics;Lung;Lung Cancer
IMPROVING INTERSTITIAL TRANSPORT IN TUMORS 5P01CA080124-08 2008-05-01 30-Apr-09 2008 JAIN, RAKESH K. MASSACHUSETTS GENERAL HOSPITAL BOSTON MA UNITED STATES NCI $318,317 Biotechnology;Breast Cancer;Cancer;Gene Therapy;Genetics
CANCER CENTER SUPPORT GRANT 3P30CA006516-44S1 1977-12-01 2008-05-07 30-Nov-08 2008 BENZ, EDWARD J DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $124,531 No NIH Category available.
SPECTROSCOPIC LOCALIZATION OF BREAST CANCER 5R44CA083597-06 1999-08-13 2008-05-08 31-Mar-09 2008 BENARON, DAVID A. SPECTROS CORPORATION Portola Valley CA UNITED STATES NCI $999,999 Bioengineering;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Prevention
PREDICTIVE BIOMARKERS OF ADJUVANT TRASTUZUMAB IN THE HER2+N9831 INTERGROUP TRIAL 1R01CA129949-01A1 2008-05-20 2008-05-20 30-Apr-09 2008 PEREZ, EDITH ADALJISA MAYO CLINIC JACKSONVILLE JACKSONVILLE FL UNITED STATES NCI $386,094 Biotechnology;Breast Cancer;Cancer;Clinical Research;Genetics
FUNCTION OF MUC4 IN MAMMARY EPITHELIA AND TUMORS 5R01CA052498-16 1991-09-30 2008-06-01 31-May-09 2008 CARRAWAY, KERMIT L. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE MIAMI FL UNITED STATES NCI $294,823 Breast Cancer;Cancer;Genetics
MECHANISMS OF INVERTEBRATE EGF RECEPTOR INHIBITION 5R01CA125432-02 2007-07-01 2008-06-01 31-May-09 2008 LEMMON, MARK A. UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA UNITED STATES NCI $236,813 Cancer
ERBB2 DOWNREGULATION THROUGH HSP90 INHIBITION 5R01CA116552-03 2007-08-01 2008-06-03 31-May-09 2008 BAND, HAMID UNIVERSITY OF NEBRASKA MEDICAL CENTER OMAHA NE UNITED STATES NCI $279,300 Biotechnology;Breast Cancer;Cancer
ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER PERMEABILIZATION IN PRIMATES 2R44NS054410-02 2008-06-15 2008-06-15 31-May-09 2008 LAWRENCE, MATTHEW SWAN RXGEN, INC. HAMDEN CT UNITED STATES NINDS $694,061 Bioengineering;Diagnostic Radiology;Neurosciences
PAUL CALABRESI PROGRAM IN CLINICAL-TRANSLATIONAL RESEARCH AT MAYO CLINIC 5K12CA090628-08 2001-09-25 2008-07-01 30-Jun-09 2008 HARTMANN, LYNN C. MAYO CLINIC ROCHESTER MN UNITED STATES NCI $1,065,864 Breast Cancer;Cancer;Clinical Research;Hematology;Orphan Drug
GROWTH FACTOR AS ANTI-ANGIOGENESIS AGENTS 5R01CA106829-05 2004-09-30 2008-07-01 30-Jun-09 2008 SEBTI, SAID M H. LEE MOFFITT CANCER CTR & RES INST TAMPA FL UNITED STATES NCI $326,968 Cancer
IN VIVO THERMOACOUSTIC IMAGING OF HER2 STATUS 5R44CA114839-04 2005-04-07 2008-07-01 30-Jun-10 2008 KRUGER, ROBERT A OPTOSONICS, INC. ORIENTAL NC UNITED STATES NCI $660,216 Bioengineering;Breast Cancer;Cancer;Diagnostic Radiology
IDENTIFICATION AND CHARACTERIZATION OF ACTIVATED TYROSINE KINASES IN GLIOBLASTOMA 5F32CA121769-02 2007-07-01 2008-07-01 31-Aug-08 2008 STOMMEL, JAYNE DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $11,757 Biotechnology;Brain Cancer;Brain Disorders;Cancer;Genetics;Neurosciences;Orphan Drug
CROSSTALK TGFBETA AND HER2 (ERBB2) SIGNALING IN MAMMARY TUMORIGENESIS 5K99CA125892-02 2007-07-25 2008-07-01 14-Sep-08 2008 WANG, SHIZHEN EMILY VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $6,941 Breast Cancer;Cancer
MOLECULAR BASIS OF SLITS AS TUMOR SUPPRESSORS CONTROLLING CXCR4/SDF1 IN BREAST 1R01CA128902-01A1 2008-07-01 2008-07-01 30-Apr-09 2008 HINCK, LINDSAY E UNIVERSITY OF CALIFORNIA SANTA CRUZ SANTA CRUZ CA UNITED STATES NCI $309,792 Breast Cancer;Cancer;Genetics
INTEGRATED BIOCHIP SENSORS FOR DETECTION OF CANCER 1R01CA120003-01A2 2008-07-01 2008-07-01 31-May-09 2008 BASHIR, RASHID UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN CHAMPAIGN IL UNITED STATES NCI $512,381 Bioengineering;Biotechnology;Breast Cancer;Cancer;Clinical Research;Nanotechnology
RADIOIMMUNOTHERAPY: CLINICAL STUDIES 5P01CA043904-17 2008-07-01 30-Jun-09 2008 WONG, JEFFREY Y CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $233,953 Breast Cancer;Cancer;Clinical Research;Clinical Trials;Colo-Rectal Cancer;Digestive Diseases
CLINICAL PRODUCTION 5P01CA043904-17 2008-07-01 30-Jun-09 2008 YAZAKI, PAUL CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $301,229 Biotechnology;Cancer;Clinical Research;Clinical Trials;Genetics
RADIOPHARMACY AND ASSAYS 5P01CA043904-17 2008-07-01 30-Jun-09 2008 COLCHER, DAVID MORRIS CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $479,620 Bioengineering;Biotechnology;Breast Cancer;Cancer;Clinical Research;Immunization
SUBPROJECT 1 5U54GM074946-04 2008-07-01 30-Jun-09 2007 EISENBERG, DAVID LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB LOS ALAMOS NM UNITED STATES NIGMS $542,189 No NIH Category available.
MOLECULAR TARGETS FOR PROGNOSIS AND THERAPY 5P50CA083636-10 2008-07-01 30-Jun-09 2008 HOOD, LEROY E FRED HUTCHINSON CANCER RESEARCH CENTER SEATTLE WA UNITED STATES NCI $567,737 Cancer;Clinical Research;Clinical Trials;Orphan Drug;Ovarian Cancer
MECHANISM OF ACTION OF DIFFERENTIATION AGENTS 5R37CA038173-23 1986-07-01 2008-07-08 30-Jun-10 2008 BRATTAIN, MICHAEL G. UNIVERSITY OF NEBRASKA MEDICAL CENTER OMAHA NE UNITED STATES NCI $321,158 Biotechnology;Breast Cancer;Cancer;Colo-Rectal Cancer;Digestive Diseases;Genetics
PROGRAM 3 (IMMUNOLOGY AND CANCER) 2P30CA014599-33 2008-07-22 2008-07-22 31-Mar-09 2008 GAJEWSKI, THOMAS F UNIVERSITY OF CHICAGO CHICAGO IL UNITED STATES NCI $15,563 Biotechnology;Cancer;Immunization;Vaccine Related
HUMAN IMMUNOLOGIC MONITORING 2P30CA014599-33 2008-07-22 2008-07-22 31-Mar-09 2008 GAJEWSKI, THOMAS F UNIVERSITY OF CHICAGO CHICAGO IL UNITED STATES NCI $80,536 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Immunization;Kidney Disease;Lymphoma;Orphan Drug;Transplantation;Vaccine Related
FATTY ACID SYNTHASE:MOLECULAR TARGET FOR BREAST CANCER THERAPY & CHEMOPREVENTION 5R01CA116623-04 2005-09-16 2008-07-30 31-Jul-08 2008 LUPU, RUTH NORTHSHORE UNIV HEALTHSYSTEM RES INST EVANSTON IL UNITED STATES NCI $70,483 Breast Cancer;Cancer;Genetics;Prevention
THE AGING GUT: REGULATION OF CELL PROLIFERATION 5R01AG014343-11 1997-09-01 2008-08-01 31-Jul-09 2008 MAJUMDAR, ADHIP N. WAYNE STATE UNIVERSITY DETROIT MI UNITED STATES NIA $227,821 Aging;Cancer;Digestive Diseases
STRUCTURAL STUDIES OF GROWTH FACTOR RECEPTOR FUNCTION 5R01CA090466-07 2001-04-01 2008-08-01 31-Jul-09 2008 LEAHY, DANIEL J JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NCI $222,384 Breast Cancer;Cancer
REWIRING ERBB SIGNALING IN CANCER CELLS 7R01CA098881-06 2003-07-01 2008-08-01 31-Jul-09 2008 LANDGRAF, RALF UNIVERSITY OF MIAMI SCHOOL OF MEDICINE MIAMI FL UNITED STATES NCI $273,042 Breast Cancer;Cancer
FATTY ACID SYNTHASE:MOLECULAR TARGET FOR BREAST CANCER THERAPY & CHEMOPREVENTION 7R01CA116623-05 2005-09-16 2008-08-01 31-May-09 2008 LUPU, RUTH MAYO CLINIC ROCHESTER MN UNITED STATES NCI $352,699 Breast Cancer;Cancer;Genetics;Prevention
HER-2/IGF-IR CROSS-TALK AND HERCEPTIN RESISTANCE 5K01CA118174-04 2006-08-01 2008-08-01 31-Jul-09 2008 NAHTA, RITA EMORY UNIVERSITY ATLANTA GA UNITED STATES NCI $143,856 Bioengineering;Biotechnology;Breast Cancer;Cancer;Nanotechnology
PROFILING ER, PR, EGFR AND HER2 IN BREAST CANCER USING MULTIPLEX TISSUE IMMUSTA 2R44CA123994-02 2006-08-01 2008-08-01 31-Jul-09 2008 JAMES, WILLIAM M 20/20 GENESYSTEMS, INC. ROCKVILLE MD UNITED STATES NCI $332,174 Bioengineering;Biotechnology;Breast Cancer;Cancer
MICELLE SURFACE ENGINEERING FOR ACTIVE TARGETING BY ACIDIC TUMOR EXTRACELLULAR PH 5R01CA122356-03 2006-08-22 2008-08-01 31-Jul-09 2008 BAE, YOU HAN UNIVERSITY OF UTAH SALT LAKE CITY UT UNITED STATES NCI $257,668 Bioengineering;Cancer
NEW BIFUNCTIONAL LIGANDS FOR RADIOIMMUNOTHERAPY 5R01CA112503-03 2006-09-01 2008-08-01 31-Jul-11 2008 CHONG, HYUN-SOON ILLINOIS INSTITUTE OF TECHNOLOGY CHICAGO IL UNITED STATES NCI $138,368 Cancer
MOLECULAR MAMMOGRAPHY OF HER-2 CANCERS USING GOLD NANOPARTICLES 4R44CA124190-02 2006-09-26 2008-08-01 31-Jul-09 2008 HAINFELD, JAMES F. NANOPROBES, INC. YAPHANK NY UNITED STATES NCI $474,069 Bioengineering;Breast Cancer;Cancer;Diagnostic Radiology;Nanotechnology
EARLY SCREENING OF BREAST LESION TRIAL (PHASE III PIVOTAL) 4R44CA126441-02 2007-09-27 2008-08-01 28-Feb-09 2008 BENARON, DAVID A. SPECTROS CORPORATION Portola Valley CA UNITED STATES NCI $866,065 Bioengineering;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Diagnostic Radiology;Prevention
A NOVEL TRANSGENIC SILKWORM SYSTEM FOR RECOMBINANT GLYCOPROTEIN PRODUCTION 5R01GM080672-02 2007-09-29 2008-08-01 31-Jul-09 2008 JARVIS, DONALD L. UNIVERSITY OF WYOMING LARAMIE WY UNITED STATES NIGMS $280,108 Bioengineering;Biotechnology
OPENING THE BLOOD BRAIN BARRIER FOR MOLECULAR IMAGING 5U41RR019703-04 2008-08-01 2008-08-01 31-Jul-09 2008 HYNYNEN, KULLERVO BRIGHAM AND WOMEN'S HOSPITAL BOSTON MA UNITED STATES NCRR $28,171 Bioengineering;Biotechnology;Brain Cancer;Brain Disorders;Breast Cancer;Cancer;Diagnostic Radiology;Nanotechnology;Neurosciences
MULTIVALENT ANTI-CANCER ANTIBODIES USING UNNATURAL AMINO ACID CHEMISTRY 1F32CA134123-01 2008-08-01 2008-08-01 31-Jul-09 2008 HUTCHINS, BENJAMIN MITCHELL SCRIPPS RESEARCH INSTITUTE LA JOLLA CA UNITED STATES NCI $46,826 Cancer
DEVELOPMENTAL RESEARCH PROGRAM 5P50CA086438-08 2008-08-01 2008-08-01 30-Jun-09 2008 JURCIC, JOSEPH G SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $87,119 Bioengineering;Biotechnology;Cancer;Diagnostic Radiology;Genetics;Hematology;Lymphoma;Orphan Drug;Regenerative Medicine;Stem Cell Research;Stem Cell Research - Nonembryonic - Human;Transplantation
MOLECULAR IMAGING OF CASTRATE- RESISTANCE METASTATIC PROSTATE CANCER 5P50CA086438-08 2008-08-01 2008-08-01 30-Jun-09 2008 LARSON, STEVEN MARK SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $111,715 Bioengineering;Cancer;Diagnostic Radiology;Nanotechnology;Prostate Cancer;Urologic Diseases
DEVELOPMENT OF METHODOLOGIES FOR THE IN VIVO IMAGING OG THE EFFECTS OF NOVEL INHI 5P50CA086438-08 2008-08-01 2008-08-01 30-Jun-09 2008 ROSEN, NEAL SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $122,547 Biotechnology;Breast Cancer;Cancer;Diagnostic Radiology
SIGNAL TRANSDUCTION IN THE HEART AFTER CANCER THERAPY 1R01HL088649-01A2 2008-08-01 2008-08-01 30-May-09 2008 GABRIELSON, KATHLEEN LOUISE JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NHLBI $410,000 Biotechnology;Cancer;Cardiovascular;Heart Disease
RESEARCH PROGRAMS-SIGNAL TRANSDUCTION 5P30CA016359-30 2008-08-01 31-Jul-09 2008 SCHLESSINGER, JOSEPH YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $27,148 Breast Cancer;Cancer;Orphan Drug
BREAST CANCER VACCINE STRATEGIES FOR HER2-OVEREXPRESSING AND LUM. B TUMORS 5P50CA058223-16 2008-08-01 31-Jul-09 2008 SERODY, JONATHAN STUART UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCI $224,073 Biotechnology;Breast Cancer;Cancer;Immunization;Infectious Diseases;Orphan Drug;Prevention;Vaccine Related;Vector-Borne Diseases
n/a 3 2010-08-31 2008-08-31 397 2E+04 Not Applicable BOSTON MA 2115 NCI NCI
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 3P50CA089393-09S4 2000-09-30 2008-09-01 31-Aug-09 2009 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $241,960 No NIH Category available.
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 5P50CA089393-09 2000-09-30 2008-09-01 31-Aug-09 2008 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $2,180,817 No NIH Category available.
INNATE IMMUNITY: ELUCIDATION AND MODULATION FOR CANCER THERAPY 5P01CA095426-07 2002-02-01 2008-09-01 31-Aug-09 2008 CALIGIURI, MICHAEL A OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $2,003,446 No NIH Category available.
DISCOVERY AND CHARACTERIZATION OF BREAST CANCER GENES 5K01CA101777-05 2004-09-07 2008-09-01 31-Aug-09 2008 HODGSON, JOHN G UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $148,770 Biotechnology;Breast Cancer;Cancer;Genetics
EX VIVO EXPANSION OF HER-2/NEU SPECIFIC T HELPER CELLS 5K01CA100764-06 2004-09-20 2008-09-01 28-Feb-10 2008 KNUTSON, KEITH L MAYO CLINIC ROCHESTER MN UNITED STATES NCI $152,658 Biotechnology;Breast Cancer;Cancer;Immunization;Prevention;Vaccine Related
UTMDACC SPORE IN BREAST CANCER 5P50CA116199-04 2005-09-23 2008-09-01 31-Aug-09 2008 HORTOBAGYI, GABRIEL N UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $2,180,817 No NIH Category available.
LIPOSOMAL DELIVERY OF HIGH LET EMITTERS TO CELL NUCLEI 5F32CA123651-03 2006-09-01 2008-09-01 31-Aug-09 2008 HAR-EL, YAH-EL JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NCI $50,428 Bioengineering;Cancer;Ovarian Cancer
REGULATION OF HER2/NEU BY ACTIVATION LOOP PHOSPHORYLATION AND ALG-2 5K22CA128951-02 2007-09-18 2008-09-01 31-Aug-09 2008 BOSE, RON WASHINGTON UNIVERSITY SAINT LOUIS MO UNITED STATES NCI $143,412 Biotechnology;Breast Cancer;Cancer;Genetics
TARGETED COMBINATIONS FOR HER2- POSITIVE BREAST CANCER BIOLOGY 5P50CA089393-09 2008-09-01 2008-09-01 31-Aug-09 2008 HARRIS, LYNDSAY N DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $80,804 Breast Cancer;Cancer
KINASE IMAGING 5P50CA086355-09 2008-09-01 2008-09-01 31-Aug-09 2008 JOSEPHSON, LEE MASSACHUSETTS GENERAL HOSPITAL BOSTON MA UNITED STATES NCI $150,344 Biotechnology;Cancer;Orphan Drug
RESEARCH PROJECT 3: ROLE OF THE NF-KB/REL IN MAMMARY CARCINOGENESIS 2P01ES011624-06A1 2008-09-01 2008-09-01 30-Jun-09 2008 SONENSHEIN, GAIL E BOSTON UNIVERSITY MEDICAL CAMPUS BOSTON MA UNITED STATES NIEHS $158,026 Breast Cancer;Cancer;Complementary and Alternative Medicine;Genetics;Nutrition
PROTOCOL SPECIFIC RESEARCH 2P30CA033572-25 2008-09-01 2008-09-01 30-Nov-08 2008 KRONTIRIS, THEODORE G CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $162,234 Brain Cancer;Brain Disorders;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Hematology;Orphan Drug
PTEN DEFICIENCY AND TRASTUZUMAB RESISTANCE 5P50CA116199-04 2008-09-01 2008-09-01 31-Aug-09 2008 YU, DIHUA UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $181,323 Cancer
BETA-CATENIN/TCF SIGNALING IN BREAST CANCER 1R01CA131219-01A1 2008-09-01 2008-09-01 31-Jul-09 2008 HOWE, LOUISE R WEILL MEDICAL COLLEGE OF CORNELL UNIV NEW YORK NY UNITED STATES NCI $345,155 Breast Cancer;Cancer;Colo-Rectal Cancer;Digestive Diseases;Prevention
MOUSE MODELING AND ANIMAL DEVELOPMENT 5P01CA095426-07 2008-09-01 31-Aug-09 2008 MUTHUSAMY, NATARAJAN OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $239,562 Biotechnology;Cancer;Genetics;Lymphoma;Orphan Drug
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21 5P01CA095426-07 2008-09-01 31-Aug-09 2008 CARSON, WILLIAM E. OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $417,272 Breast Cancer;Cancer;Immunization
HSP90 AS A TARGET FOR MECHANISM-BASED THERAPY FOR CASTRATION-RESISTANT PROSTATE C 5P50CA092629-08 2008-09-01 31-Aug-09 2008 ROSEN, NEAL SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $418,592 Aging;Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Orphan Drug;Prostate Cancer;Urologic Diseases
COMBINATORIAL LIBRARY SCREENING CORE 5U54CA119343-04 2008-09-01 31-Aug-09 2008 LIU, RIHE UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCI $433,439 Bioengineering;Biotechnology;Cancer;Clinical Research;Clinical Trials;Nanotechnology
TWO COMPARTMENT MODELS TO IMPROVE BRAIN TUMOR THERAPY 9R01CA137488-14A1 1995-08-15 2008-09-05 31-Aug-09 2008 NEUWELT, EDWARD A OREGON HEALTH AND SCIENCE UNIVERSITY PORTLAND OR UNITED STATES NCI $494,277 Brain Cancer;Brain Disorders;Breast Cancer;Cancer;Clinical Research;Lymphoma;Neurodegenerative;Neurosciences
IDENTIFICATION AND CHARACTERIZATION OF DRIVER GENE(S) IN RECURRENT LUNG CANCER AM 1R01CA127547-01A1 2008-09-08 2008-09-08 31-Jul-09 2008 MU, DAVID PENNSYLVANIA STATE UNIV HERSHEY MED CTR HERSHEY PA UNITED STATES NCI $287,938 Biotechnology;Cancer;Genetics;Lung;Lung Cancer
HUMAN MUC1 MUC1 ONCOPROTEIN: DEVELOPMENT OF MUC1-DECOY SOLUBLE RECEPTORS AS ANTI- 1R43CA135758-01 2008-09-09 2008-09-09 28-Feb-10 2008 RAINA, DEEPAK GENUS ONCOLOGY, LLC CHICAGO IL UNITED STATES NCI $100,000 Cancer;Hematology;Orphan Drug
DETERMINANTS AND RISKS OF USE AND OVERUSE OF EXPENSIVE ONCOLOGY DRUGS 1R01CA134964-01 2008-09-12 2008-09-12 31-Jul-09 2008 HERSHMAN, DAWN COLUMBIA UNIVERSITY HEALTH SCIENCES NEW YORK NY UNITED STATES NCI $259,686 Aging;Breast Cancer;Cancer;Clinical Research;Health Services;Hematology;Prostate Cancer;Urologic Diseases
NOVEL TACE INHIBITORS FOR BREAST CANCER THERAPY 1R43CA128183-01A1 2008-09-15 2008-09-15 31-Aug-10 2008 MENDELSOHN, ANDREW R PANORAMA RESEARCH, INC. SUNNYVALE CA UNITED STATES NCI $192,060 Biotechnology;Breast Cancer;Cancer
MEASUREMENT IN DIVERSE POPULATIONS 1P01CA130818-01A1 2008-07-01 2008-09-16 31-Aug-09 2008 PONCE, NINEZ ALAFRIZ UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $76,088 Bioengineering;Cancer
ECONOMICS OF PERSONALIZED MEDICINE USING GENOMICS 1P01CA130818-01A1 2008-07-01 2008-09-16 31-Aug-09 2008 LADABAUM, URI UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $190,625 Bioengineering;Cancer;Clinical Research;Cost Effectiveness Research;Health Services;Prevention
UTILIZATION OF PERSONALIZED MEDICINE USING GENOMICS 1P01CA130818-01A1 2008-07-01 2008-09-16 31-Aug-09 2008 HAAS, JENNIFER S UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $514,902 Bioengineering;Biotechnology;Breast Cancer;Cancer;Clinical Research;Genetics;Health Services
PERSONALIZED MEDICINE FOR COLORECTAL AND BREAST CANCER 1P01CA130818-01A1 2008-09-16 2008-09-16 31-Aug-09 2008 PHILLIPS, KATHRYN A UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $1,767,837 No NIH Category available.
ANTI-CANCER DRIG SENSITIZERS 1R43CA132207-01 2008-09-19 2008-09-19 31-Mar-09 2008 ROYER, ROBERT E. QUATROS RESEARCH AND DEVELOPMENT, LLC ALBUQUERQUE NM UNITED STATES NCI $135,800 Breast Cancer;Cancer;Orphan Drug
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 3P50CA089393-09S2 2000-09-30 2008-09-22 31-Aug-09 2008 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $237,500 No NIH Category available.
NONINVASIVE ASSESSMENT OF CANCER RESPONSIVENESS TO THERAPY BY USE OF ..... 1P50CA128323-01A1 2008-09-22 2008-09-22 31-Aug-09 2008 HALLAHAN, DENNIS E VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $104,362 Cancer;Diagnostic Radiology;Orphan Drug
IMMUNOBIOLOGY OF P185 RECEPTOR 2R01CA055306-14A1 1992-05-01 2008-09-24 31-Jul-09 2008 GREENE, MARK I UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA UNITED STATES NCI $269,183 Biotechnology;Cancer;Immunization;Prevention
DISSECTING MECHANISMS OF METASTASIS THROUGH COMPARATIVE SYSTEMS GENETICS 1R01CA138265-01 2008-09-25 2008-09-25 31-Jul-09 2008 KIRSCH, DAVID G DUKE UNIVERSITY DURHAM NC UNITED STATES NCI $463,000 Biotechnology;Breast Cancer;Cancer;Genetics
TARGETED ALPHA-PARTICLE EMITTER THERAPY OF METASTASES 5R01CA113797-04 2005-12-09 2008-12-01 30-Nov-09 2009 SGOUROS, GEORGE JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NCI $278,677 Breast Cancer;Cancer;Digestive Diseases;Liver Disease
BRK SIGNALS TO ERK5 IN BREAST CANCER 5R01CA107547-03 2006-12-15 2008-12-01 30-Nov-09 2009 LANGE, CAROL ANN UNIVERSITY OF MINNESOTA TWIN CITIES MINNEAPOLIS MN UNITED STATES NCI $249,308 Breast Cancer;Cancer
DETERMINATION OF DISTINCT TYPES OF IMMUNE RESPONSES TO HER-2/NEU ASSOCIATED W 5M01RR000065-47 2008-12-01 2008-12-01 30-Nov-09 2009 MANJILI, MASOUD H VIRGINIA COMMONWEALTH UNIVERSITY RICHMOND VA UNITED STATES NCRR $3,733 Breast Cancer;Cancer;Clinical Research
TARGETING THE HER2 PATHWAY: MECHANISMS OF RESISTANCE & STRATEGIES TO OVERCOME 5P50CA058183-15 2008-12-01 30-Nov-09 2009 OSBORNE, C KENT BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $163,036 No NIH Category available.
NOVEL TREATMENT OF NF-1 ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS 5R01CA122804-02 2007-12-07 2008-12-17 30-Nov-09 2009 CARROLL, STEVEN L UNIVERSITY OF ALABAMA AT BIRMINGHAM BIRMINGHAM AL UNITED STATES NCI $300,875 Biotechnology;Breast Cancer;Cancer;Neurofibromatosis;Neurosciences
TSG101 - A MODULATOR OF ERBB2 SIGNALING IN BREAST CANCER 2R01CA093797-06A2 2002-01-01 2009-01-01 31-Dec-09 2009 WAGNER, KAY-UWE UNIVERSITY OF NEBRASKA MEDICAL CENTER OMAHA NE UNITED STATES NCI $265,863 Breast Cancer;Cancer
PROSPECTIVE VALIDATION OF GENOMIC SIGNATURES OF CHEMOSENSITIVITY IN NSCLC 1R01CA131049-01A1 2009-01-01 2009-01-01 30-Nov-09 2009 POTTI, ANIL DUKE UNIVERSITY DURHAM NC UNITED STATES NCI $340,464 Biotechnology;Cancer;Clinical Research;Genetics;Lung;Lung Cancer
ERBB RECEPTOR HOMO- AND HETERO-DIMERIZATION 2R01CA079992-11 1999-02-01 2009-02-01 31-Dec-09 2009 LEMMON, MARK A. UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA UNITED STATES NCI $255,723 Breast Cancer;Cancer
SIGNALING BY NEUREGULINS AND ERBB4 IN BREAST CANCER 2R01CA080065-09A2 1999-07-01 2009-02-01 30-Nov-09 2009 STERN, DAVID F YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $391,179 Breast Cancer;Cancer;Lung;Lung Cancer
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 3P50CA089393-09S3 2000-09-30 2009-02-01 31-Aug-09 2009 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $24,615 Breast Cancer;Cancer
REGULATION OF ERBB2/NEU-INDUCED MAMMARY GLAND CANCER 3R01CA090398-08S1 2001-03-05 2009-02-01 31-Jan-10 2009 KERI, RUTH A CASE WESTERN RESERVE UNIVERSITY CLEVELAND OH UNITED STATES NCI $86,339 Breast Cancer;Cancer;Genetics
REGULATION OF ERBB2/NEU-INDUCED MAMMARY GLAND CANCER 5R01CA090398-08 2001-03-05 2009-02-01 31-Jan-10 2009 KERI, RUTH A CASE WESTERN RESERVE UNIVERSITY CLEVELAND OH UNITED STATES NCI $213,979 Breast Cancer;Cancer;Genetics
TARGETING JAB1 ONCOGENIC FUNCTION IN BREAST CANCER 5R01CA090853-08 2001-04-01 2009-02-01 31-Jan-10 2009 CLARET, FRANCOIS X UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $255,009 Biotechnology;Breast Cancer;Cancer;Genetics
THE ROLE OF SYNDECAN-1 IN MOUSE MAMMARY NEOPLASIA 5R01CA090877-07 2001-04-01 2009-02-01 31-Jan-10 2009 ALEXANDER, CAROLINE MARGARET UNIVERSITY OF WISCONSIN MADISON MADISON WI UNITED STATES NCI $295,173 Breast Cancer;Cancer;Stem Cell Research;Stem Cell Research - Nonembryonic - Non-Human
PHARMACODYNAMIC ASSESSMENT OF RTK INHIBITORS IN CANCER 5R01CA112385-05 2005-02-23 2009-02-01 31-Aug-09 2009 HALLAHAN, DENNIS E VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $71,937 Cancer;Diagnostic Radiology;Lung;Lung Cancer;Orphan Drug
SYNDECAN-1 IN STROMAL FIBROBLASTS OF BREAST CARCINOMAS 5R01CA107012-05 2005-03-01 2009-02-01 31-Jan-10 2009 FRIEDL, ANDREAS UNIVERSITY OF WISCONSIN MADISON MADISON WI UNITED STATES NCI $269,030 Breast Cancer;Cancer;Clinical Research
NSABP PARTICIPATING SITES 5U10CA118735-04 2006-04-10 2009-02-01 31-Jan-10 2009 CHANG, JENNY C-N BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $67,765 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Health Disparities;Minority Health
REGULATION OF STAT3 SIGNALING 5R01CA122910-03 2007-04-01 2009-02-01 31-Jan-10 2009 REICH, NANCY C. STATE UNIVERSITY NEW YORK STONY BROOK STONY BROOK NY UNITED STATES NCI $294,500 Cancer;Genetics;Hematology
CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING 4R44CA130026-02 2007-09-28 2009-02-01 31-Jan-10 2009 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION WOBURN MA UNITED STATES NCI $900,963 Bioengineering;Biotechnology;Breast Cancer;Cancer
ROLES OF NF-KB/REL IN THE PATHOGENESIS OF BREAST CANCER 5R01CA129129-02 2008-04-01 2009-02-01 31-Dec-09 2009 SONENSHEIN, GAIL E BOSTON UNIVERSITY MEDICAL CAMPUS BOSTON MA UNITED STATES NCI $337,188 Breast Cancer;Cancer;Complementary and Alternative Medicine;Genetics;Nutrition
PREDICTION OF NEOADJUVANT CHEMO PATHOLOGICAL RESPONSE USING MRI MARKERS 5R01CA127927-02 2008-04-01 2009-02-01 31-Jan-10 2009 SU, MIN-YING L UNIVERSITY OF CALIFORNIA IRVINE IRVINE CA UNITED STATES NCI $503,017 Breast Cancer;Cancer;Clinical Research;Diagnostic Radiology
MECHANISMS OF TUMOR RESISTANCE TO ANTI-HER/ERBB THERAPEUTICS 5R01CA129036-02 2008-04-02 2009-02-01 31-Jan-10 2009 FAN, ZHEN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $319,550 Biotechnology;Breast Cancer;Cancer;Hematology
DETERMINANTS OF TUMOR SENSITIVITY TO EGFR-TARGETED ANTIBODIES 2R01CA050633-19A1 1989-06-01 2009-02-02 31-Dec-09 2009 WEINER, LOUIS M GEORGETOWN UNIVERSITY WASHINGTON DC UNITED STATES NCI $352,183 Biotechnology;Cancer;Genetics;Immunization
TRANSLATIONAL RESEARCH IN BREAST CANCER 5P50CA058183-15 1992-09-30 2009-02-17 30-Nov-09 2009 OSBORNE, C KENT BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $2,300,000 Aging;Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Estrogen;Prevention;Stem Cell Research;Stem Cell Research - Nonembryonic - Human
CROSSTALK TGFBETA AND HER2 (ERBB2) SIGNALING IN MAMMARY TUMORIGENESIS 7K99CA125892-03 2007-07-25 2009-02-23 30-Jun-09 2008 WANG, SHIZHEN EMILY CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $113,529 No NIH Category available.
PREDICTION OF CHEMOTHERAPY INDUCED CARDIOMYOPATHY WITH MRI DETECT I 5M01RR007122-18 2009-03-01 2009-03-01 28-Feb-10 2009 HUNDLEY, WILLIAM GREGORY WAKE FOREST UNIVERSITY HEALTH SCIENCES WINSTON-SALEM NC UNITED STATES NCRR $81,758 Cancer;Cardiovascular;Clinical Research;Diagnostic Radiology;Heart Disease;Heart Disease - Coronary Heart Disease
CELL HETEROGENEITY AND EMERGENT TRASTUZUMAB RESISTANCE IN BREAST CANCER: CONCEPT 1R15CA132124-01A2 2009-03-01 2009-03-01 28-Feb-11 2009 KLINKE, DAVID JOHN WEST VIRGINIA UNIVERSITY MORGANTOWN WV UNITED STATES NCI $219,750 Bioengineering;Breast Cancer;Cancer
TAKE HEART: EXERCISE & DIET INTERVENTION FOR HEART FAILURE IN CANCER SURVIVORS 1R21CA135016-01A1 2009-03-13 2009-03-13 28-Feb-10 2009 BASEN-ENGQUIST, KAREN M UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $169,400 Behavioral and Social Science;Cancer;Cardiovascular;Clinical Research;Heart Disease;Mind and Body;Nutrition;Prevention;Rehabilitation
BRAIN TUMORS - IMMUNOLOGICAL AND BIOLOGICAL STUDIES 5R37CA011898-39 1976-12-01 2009-04-01 31-Mar-10 2009 BIGNER, DARELL D DUKE UNIVERSITY DURHAM NC UNITED STATES NCI $690,468 Brain Cancer;Brain Disorders;Cancer;Clinical Research;Clinical Trials;Neurosciences;Orphan Drug
NEXT GENERATION STRATEGIES TO INTERCEPT ERBB SIGNALING 5R37CA072981-13 1997-04-25 2009-04-01 31-Mar-10 2009 YARDEN, YOSEF NONE WEIZMANN INSTITUTE OF SCIENCE REHOVOT ISRAEL NCI $230,408 Biotechnology;Cancer;Prevention
TARGETING THE IGF SYSTEM IN BREAST CANCER 5R01CA074285-12 1998-01-01 2009-04-01 28-Feb-10 2009 YEE, DOUGLAS UNIVERSITY OF MINNESOTA TWIN CITIES MINNEAPOLIS MN UNITED STATES NCI $354,167 Breast Cancer;Cancer
SPECTROSCOPIC LOCALIZATION OF BREAST CANCER 5R44CA083597-07 1999-08-13 2009-04-01 31-Mar-11 2009 BENARON, DAVID A. SPECTROS CORPORATION Portola Valley CA UNITED STATES NCI $982,695 Aging;Bioengineering;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Health Disparities;Minority Health
STRUCTURE-BASED PREDICTION OF THE INTERACTOME 5R01GM081871-02 2008-04-01 2009-04-01 31-Mar-10 2009 BERGER, BONNIE MASSACHUSETTS INSTITUTE OF TECHNOLOGY CAMBRIDGE MA UNITED STATES NIGMS $293,189 Bioengineering;Biotechnology;Genetics;Human Genome;Networking and Information Technology R&D
CLINICAL TRIAL: P III TRIAL OF DOXORUBICIN & CYCLOPHOSPHAMIDE FOL BY WEEKLY PACL 5M01RR010732-15 2009-04-01 2009-04-01 31-Mar-10 2009 RYBKA, WITOLD B. PENNSYLVANIA STATE UNIV HERSHEY MED CTR HERSHEY PA UNITED STATES NCRR $7,395 Breast Cancer;Cancer;Clinical Research;Clinical Trials
PROGRAM 3 (IMMUNOLOGY AND CANCER) 5P30CA014599-34 2009-04-01 31-Mar-10 2009 GAJEWSKI, THOMAS F UNIVERSITY OF CHICAGO CHICAGO IL UNITED STATES NCI $24,656 Biotechnology;Cancer;Immunization;Stem Cell Research;Stem Cell Research - Nonembryonic - Human;Transplantation;Vaccine Related
HUMAN IMMUNOLOGIC MONITORING 5P30CA014599-34 2009-04-01 31-Mar-10 2009 GAJEWSKI, THOMAS F UNIVERSITY OF CHICAGO CHICAGO IL UNITED STATES NCI $127,583 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Immunization;Orphan Drug;Stem Cell Research;Stem Cell Research - Nonembryonic - Human;Transplantation;Vaccine Related
MODULATION BY BOTANICALS OF ANTIBODY BASED CANCER IMMUNOTHERAPY 5P50AT002779-05 2009-04-01 31-Mar-10 2009 CHEUNG, NAI-KONG V SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCCAM $269,759 Biotechnology;Cancer;Complementary and Alternative Medicine;Immunization;Prevention;Vaccine Related
ROLE OF NEUREGULIN/ERBB SIGNALING IN THE ADULT HEART 5R01HL068144-09 2001-09-30 2009-04-02 31-Mar-11 2009 SAWYER, DOUGLAS B VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NHLBI $327,478 Cardiovascular;Heart Disease
WOMEN'S CANCERS 2P30CA016042-34 2009-04-02 2009-04-02 30-Nov-09 2009 GLASPY, JOHN A UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $66,090 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Genetics;Nutrition;Prevention
SENIOR LEADERS 2P30CA016042-34 2009-04-02 2009-04-02 30-Nov-09 2009 GASSON, JUDITH CHERYL UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $737,786 Breast Cancer;Cancer;Genetics
SOLUBLE TCR-IL15 FUSIONS AS TARGETED THERAPEUTICS FOR CANCER 1R43CA139810-01 2009-04-03 2009-04-03 2-Apr-10 2009 RHODE, PETER R ALTOR BIOSCIENCE CORPORATION MIRAMAR FL UNITED STATES NCI $202,736 Biotechnology;Cancer
THE AGING GUT: REGULATION OF CELL PROLIFERATION 3R01AG014343-11S1 1997-09-01 2009-04-15 31-Jul-09 2009 MAJUMDAR, ADHIP N. WAYNE STATE UNIVERSITY DETROIT MI UNITED STATES NIA $21,484 Aging;Cancer;Digestive Diseases
MOLECULAR STUDIES OF ESOPHAGEAL ADENOCARCINOMA 5R01CA071606-13 1997-06-05 2009-05-01 30-Apr-10 2009 BEER, DAVID GEORGE UNIVERSITY OF MICHIGAN AT ANN ARBOR ANN ARBOR MI UNITED STATES NCI $305,930 Biotechnology;Cancer;Clinical Research;Digestive Diseases;Genetics
BREAST CANCER RESPONSE MARKERS TO A DUAL HER1/2 BLOCKER 5R01CA112305-05 2005-06-16 2009-05-01 30-Apr-10 2009 CHANG, JENNY C-N BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $252,236 Breast Cancer;Cancer;Clinical Research;Genetics
FUNCTIONS IN TUMORS OF RECURRENTLY AMPLIFIED PREFOLDIN-4 5R01CA112608-05 2005-07-25 2009-05-01 30-Apr-10 2009 HANAHAN, DOUGLAS UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $283,709 Biotechnology;Breast Cancer;Cancer;Genetics
PREDICTIVE BIOMARKERS OF ADJUVANT TRASTUZUMAB IN THE HER2+N9831 INTERGROUP TRIAL 5R01CA129949-02 2008-05-20 2009-05-01 30-Apr-10 2009 PEREZ, EDITH ADALJISA MAYO CLINIC JACKSONVILLE JACKSONVILLE FL UNITED STATES NCI $483,070 Biotechnology;Breast Cancer;Cancer;Clinical Research;Genetics
MOLECULAR BASIS OF SLITS AS TUMOR SUPPRESSORS CONTROLLING CXCR4/SDF1 IN BREAST 3R01CA128902-02S1 2008-07-01 2009-05-01 30-Apr-10 2009 HINCK, LINDSAY E UNIVERSITY OF CALIFORNIA SANTA CRUZ SANTA CRUZ CA UNITED STATES NCI $71,614 Breast Cancer;Cancer;Genetics
MOLECULAR BASIS OF SLITS AS TUMOR SUPPRESSORS CONTROLLING CXCR4/SDF1 IN BREAST 5R01CA128902-02 2008-07-01 2009-05-01 30-Apr-10 2009 HINCK, LINDSAY E UNIVERSITY OF CALIFORNIA SANTA CRUZ SANTA CRUZ CA UNITED STATES NCI $309,335 Breast Cancer;Cancer;Genetics
TARGETING HER-2 PROTEIN FOR BREAST CANCER USING COMPUTATIONAL APPROACH 5P20RR016456-08 2009-05-01 2009-05-01 30-Apr-10 2009 SATYANARAYANAJOIS, SEETHARAMA D LOUISIANA STATE UNIV A&M COL BATON ROUGE BATON ROUGE LA UNITED STATES NCRR $42,225 Biotechnology;Breast Cancer;Cancer
CELL HETEROGENEITY AND EMERGENT TRASTUZUMAB RESISTANCE IN BREAST CANCER: CONCEPT 3R15CA132124-01A2S3 2009-05-01 2009-05-01 28-Feb-11 2009 KLINKE, DAVID JOHN WEST VIRGINIA UNIVERSITY MORGANTOWN WV UNITED STATES NCI $51,890 Bioengineering;Breast Cancer;Cancer
METABOLIC PHENOTYPING WITH PET TO MONITOR AND PREDICT RESPONSE TO KINASE 5P50CA086306-10 2009-05-01 30-Apr-10 2009 CZERNIN, JOHANNES UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $257,338 Bioengineering;Biotechnology;Brain Cancer;Brain Disorders;Cancer;Clinical Research;Diagnostic Radiology;Genetics;Lung;Lung Cancer
IMPROVING INTERSTITIAL TRANSPORT IN TUMORS 5P01CA080124-09 2009-05-01 30-Apr-10 2009 JAIN, RAKESH K. MASSACHUSETTS GENERAL HOSPITAL BOSTON MA UNITED STATES NCI $304,190 Biotechnology;Breast Cancer;Cancer;Gene Therapy;Genetics
DEVELOPMENT OF MECHANISM-BASED STRATEGIES FOR THE TREATMENT OF ADVANCED BREAST CA 5P01CA094060-07 2009-05-01 30-Apr-10 2009 ROSEN, NEAL SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $447,626 Breast Cancer;Cancer;Clinical Research
SMALL MOLECULE INHIBITORS OF THE TRANSCRIPTIONAL ACTIVATORS ESX AND NF-KB 1R01CA140667-01 2009-05-20 2009-05-20 28-Feb-10 2009 MAPP, ANNA K. UNIVERSITY OF MICHIGAN AT ANN ARBOR ANN ARBOR MI UNITED STATES NCI $319,862 Breast Cancer;Cancer;Genetics
FUNCTION OF MUC4 IN MAMMARY EPITHELIA AND TUMORS 5R01CA052498-17 1991-09-30 2009-06-01 31-May-10 2009 CARRAWAY, KERMIT L. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE MIAMI FL UNITED STATES NCI $294,823 Biotechnology;Breast Cancer;Cancer;Genetics
MECHANISMS OF INVERTEBRATE EGF RECEPTOR INHIBITION 5R01CA125432-03 2007-07-01 2009-06-01 31-May-10 2009 LEMMON, MARK A. UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA UNITED STATES NCI $236,735 Breast Cancer;Cancer
ERBB2 DOWNREGULATION THROUGH HSP90 INHIBITION 5R01CA116552-04 2007-08-01 2009-06-01 31-May-10 2009 BAND, HAMID UNIVERSITY OF NEBRASKA MEDICAL CENTER OMAHA NE UNITED STATES NCI $279,300 Biotechnology;Breast Cancer;Cancer
ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER PERMEABILIZATION IN PRIMATES 5R44NS054410-03 2008-06-15 2009-06-01 31-May-10 2009 LAWRENCE, MATTHEW SWAN RXGEN, INC. HAMDEN CT UNITED STATES NINDS $668,381 Bioengineering;Diagnostic Radiology;Neurosciences
INTEGRATED BIOCHIP SENSORS FOR DETECTION OF CANCER 5R01CA120003-02 2008-07-01 2009-06-01 31-May-10 2009 BASHIR, RASHID UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN CHAMPAIGN IL UNITED STATES NCI $522,787 Bioengineering;Biotechnology;Breast Cancer;Cancer;Clinical Research;Nanotechnology
SIGNAL TRANSDUCTION IN THE HEART AFTER CANCER THERAPY 5R01HL088649-02 2008-08-01 2009-06-01 31-May-10 2009 GABRIELSON, KATHLEEN LOUISE JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NHLBI $410,000 Biotechnology;Breast Cancer;Cancer;Cardiovascular;Heart Disease
IDENTIFICATION AND CHARACTERIZATION OF DRIVER GENE(S) IN RECURRENT LUNG CANCER AM 3R01CA127547-01A1S1 2009-06-01 2009-06-01 30-Sep-10 2009 MU, DAVID PENNSYLVANIA STATE UNIV HERSHEY MED CTR HERSHEY PA UNITED STATES NCI $38,411 Biotechnology;Cancer;Genetics;Lung;Lung Cancer
CELL HETEROGENEITY AND EMERGENT TRASTUZUMAB RESISTANCE IN BREAST CANCER: CONCEPT 3R15CA132124-01A2S2 2009-06-01 2009-06-01 30-Sep-10 2009 KLINKE, DAVID JOHN WEST VIRGINIA UNIVERSITY MORGANTOWN WV UNITED STATES NCI $39,496 Bioengineering;Breast Cancer;Cancer
CANCER AND LEUKEMIA GROUP B 3U10CA031946-28S1 2009-06-01 2009-06-01 31-Mar-10 2009 SCHILSKY, RICHARD L UNIVERSITY OF CHICAGO CHICAGO IL UNITED STATES NCI $201,363 Cancer
DEVELOPMENT OF PROBODIES: A NOVEL CLASS OF THERAPEUTIC ANTIBODIES COMBINING TARGE 1R43CA139790-01 2009-06-01 2009-06-01 31-May-11 2009 WEST, JAMES W CYTOMX THERAPEUTICS, LLC SANTA BARBARA CA UNITED STATES NCI $260,910 Arthritis;Biotechnology;Cancer;Immunization;Lung;Lung Cancer
NR1D1 PATHWAY IN BREAST CANCER 1R01CA136658-01A1 2009-06-01 2009-06-01 30-Apr-10 2009 CONKLIN, DOUGLAS S STATE UNIVERSITY OF NEW YORK AT ALBANY ALBANY NY UNITED STATES NCI $314,363 Biotechnology;Breast Cancer;Cancer;Genetics;Nutrition
THE ROLE OF AURORA KINASE A IN UPPER GASTROINTESTINAL ADENOCARCINOMAS 1R01CA131225-01A2 2009-06-01 2009-06-01 30-Apr-10 2009 EL-RIFAI, WAEL VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $314,534 Cancer;Digestive Diseases;Genetics
EARLY SCREENING OF BREAST LESION TRIAL (PHASE III PIVOTAL) 5R44CA126441-03 2007-09-27 2009-06-26 28-Feb-10 2009 BENARON, DAVID A. SPECTROS CORPORATION Portola Valley CA UNITED STATES NCI $701,169 Bioengineering;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Diagnostic Radiology;Prevention;Prostate Cancer;Urologic Diseases
PAUL CALABRESI PROGRAM IN CLINICAL-TRANSLATIONAL RESEARCH AT MAYO CLINIC 5K12CA090628-09 2001-09-25 2009-07-01 30-Jun-10 2009 HARTMANN, LYNN C. MAYO CLINIC ROCHESTER MN UNITED STATES NCI $1,070,823 Breast Cancer;Cancer;Clinical Research;Hematology;Orphan Drug
DEVELOPMENTAL RESEARCH PROGRAM 5P50CA086438-09 2009-07-01 30-Jun-10 2009 JURCIC, JOSEPH G SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $159,080 Bioengineering;Biotechnology;Cancer;Diagnostic Radiology;Genetics;Hematology;Lymphoma;Nanotechnology;Orphan Drug;Regenerative Medicine;Transplantation
RESEARCH PROJECT 3: ROLE OF THE NF-KB/REL IN MAMMARY CARCINOGENESIS 5P01ES011624-07 2009-07-01 30-Jun-10 2009 SONENSHEIN, GAIL E BOSTON UNIVERSITY MEDICAL CAMPUS BOSTON MA UNITED STATES NIEHS $162,768 Breast Cancer;Cancer;Complementary and Alternative Medicine;Genetics;Nutrition
MOLECULAR IMAGING OF CASTRATE- RESISTANCE METASTATIC PROSTATE CANCER 5P50CA086438-09 2009-07-01 30-Jun-10 2009 LARSON, STEVEN MARK SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $203,991 Bioengineering;Cancer;Diagnostic Radiology;Nanotechnology;Prostate Cancer;Urologic Diseases
DEVELOPMENT OF METHODOLOGIES FOR THE IN VIVO IMAGING OG THE EFFECTS OF NOVEL INHI 5P50CA086438-09 2009-07-01 30-Jun-10 2009 ROSEN, NEAL SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $223,770 Bioengineering;Biotechnology;Breast Cancer;Cancer;Diagnostic Radiology;Nanotechnology
RADIOIMMUNOTHERAPY: CLINICAL STUDIES 5P01CA043904-18 2009-07-01 30-Jun-10 2009 WONG, JEFFREY Y CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $241,076 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Colo-Rectal Cancer;Digestive Diseases;Immunization;Vaccine Related
CLINICAL PRODUCTION 5P01CA043904-18 2009-07-01 30-Jun-10 2009 YAZAKI, PAUL CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $310,412 Biotechnology;Cancer;Clinical Research;Clinical Trials;Genetics
RADIOPHARMACY AND ASSAYS 5P01CA043904-18 2009-07-01 30-Jun-10 2009 COLCHER, DAVID MORRIS CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $494,263 Bioengineering;Biotechnology;Breast Cancer;Cancer;Clinical Research;Colo-Rectal Cancer;Digestive Diseases;Immunization;Vaccine Related
SUBPROJECT 1 5U54GM074946-05 2009-07-01 30-Jun-10 2008 EISENBERG, DAVID LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB LOS ALAMOS NM UNITED STATES NIGMS $542,456 Bioengineering;Biotechnology;Genetics
THE IMPLEMENTATION OF A PHARMACOGENOMICS-BASED ALGORITHM FOR WARFARIN DOSING 1K23HL089808-01A2 2009-07-15 2009-07-15 30-Apr-10 2009 PERERA, MINOLI UNIVERSITY OF CHICAGO CHICAGO IL UNITED STATES NHLBI $119,233 Clinical Research;Clinical Trials;Genetic Testing;Genetics;Health Disparities;Human Genome;Minority Health
SIGNAL TRANSDUCTION IN THE HEART AFTER CANCER THERAPY 3R01HL088649-01A2S1 2009-07-15 2009-07-15 30-Jun-11 2009 GABRIELSON, KATHLEEN LOUISE JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NHLBI $269,045 Biotechnology;Breast Cancer;Cancer;Cardiovascular;Heart Disease
MONITORING BREAST CANCER CHEMOTHERAPEUTIC RESPONSE USING DOSI, MRI AND BIOMARKERS 1U54CA136400-01 2009-07-17 2009-07-17 30-Jun-10 2009 TROMBERG, BRUCE J UNIVERSITY OF CALIFORNIA IRVINE IRVINE CA UNITED STATES NCI $452,201 Bioengineering;Breast Cancer;Cancer;Clinical Research;Diagnostic Radiology
FATTY ACID SYNTHASE:MOLECULAR TARGET FOR BREAST CANCER THERAPY & CHEMOPREVENTION 5R01CA116623-06 2005-09-16 2009-07-31 28-Feb-11 2009 LUPU, RUTH MAYO CLINIC ROCHESTER MN UNITED STATES NCI $444,316 Breast Cancer;Cancer;Genetics;Prevention
IMMUNOBIOLOGY OF P185 RECEPTOR 5R01CA055306-15 1992-05-01 2009-08-01 31-Jul-10 2009 GREENE, MARK I UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA UNITED STATES NCI $269,183 Biotechnology;Cancer;Immunization;Prevention
THE AGING GUT: REGULATION OF CELL PROLIFERATION 5R01AG014343-12 1997-09-01 2009-08-01 31-Jul-10 2009 MAJUMDAR, ADHIP N. WAYNE STATE UNIVERSITY DETROIT MI UNITED STATES NIA $294,023 Aging;Cancer;Digestive Diseases
STRUCTURAL STUDIES OF GROWTH FACTOR RECEPTOR FUNCTION 5R01CA090466-08 2001-04-01 2009-08-01 31-Jul-10 2009 LEAHY, DANIEL J JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NCI $222,384 Breast Cancer;Cancer
BREAST CANCER TREATMENT WITH ANTIBODY TARGETED T CELLS 2R01CA092344-07A2 2001-07-01 2009-08-01 31-Jul-10 2009 LUM, LAWRENCE G WAYNE STATE UNIVERSITY DETROIT MI UNITED STATES NCI $501,226 Breast Cancer;Cancer;Clinical Research;Clinical Trials;Immunization;Vaccine Related
STRUCTURE/FUNCTION STUDIES OF NUCLEOSIDE ANALOG ACTIVATING ENZYMES 2R56CA095687-05A1 2002-08-22 2009-08-01 31-Jul-11 2009 LAVIE, ARNON UNIVERSITY OF ILLINOIS AT CHICAGO CHICAGO IL UNITED STATES NCI $266,973 Cancer
THE MOLECULAR ACTIONS OF IMATINIB MESYLATE IN GISTS 2R01CA106588-06 2004-05-01 2009-08-01 31-May-10 2009 GODWIN, ANDREW K FOX CHASE CANCER CENTER PHILADELPHIA PA UNITED STATES NCI $423,095 Biotechnology;Cancer;Clinical Research;Clinical Trials;Colo-Rectal Cancer;Digestive Diseases;Genetics;Orphan Drug;Prevention
HER-2/IGF-IR CROSS-TALK AND HERCEPTIN RESISTANCE 5K01CA118174-05 2006-08-01 2009-08-01 31-Jul-10 2009 NAHTA, RITA EMORY UNIVERSITY ATLANTA GA UNITED STATES NCI $143,856 Bioengineering;Biotechnology;Breast Cancer;Cancer;Nanotechnology
MICELLE SURFACE ENGINEERING FOR ACTIVE TARGETING BY ACIDIC TUMOR EXTRACELLULAR PH 5R01CA122356-04 2006-08-22 2009-08-01 31-Jul-10 2009 BAE, YOU HAN UNIVERSITY OF UTAH SALT LAKE CITY UT UNITED STATES NCI $257,668 Bioengineering;Cancer
MOLECULAR MAMMOGRAPHY OF HER-2 CANCERS USING GOLD NANOPARTICLES 5R44CA124190-03 2006-09-26 2009-08-01 31-Jul-11 2009 HAINFELD, JAMES F. NANOPROBES, INC. YAPHANK NY UNITED STATES NCI $483,193 Bioengineering;Breast Cancer;Cancer;Diagnostic Radiology;Nanotechnology
A NOVEL TRANSGENIC SILKWORM SYSTEM FOR RECOMBINANT GLYCOPROTEIN PRODUCTION 5R01GM080672-03 2007-09-29 2009-08-01 31-Jul-10 2009 JARVIS, DONALD L. UNIVERSITY OF WYOMING LARAMIE WY UNITED STATES NIGMS $280,108 Bioengineering;Biotechnology
BETA-CATENIN/TCF SIGNALING IN BREAST CANCER 5R01CA131219-02 2008-09-01 2009-08-01 31-Jul-10 2009 HOWE, LOUISE R WEILL MEDICAL COLLEGE OF CORNELL UNIV NEW YORK NY UNITED STATES NCI $350,675 Aging;Breast Cancer;Cancer;Prevention
IDENTIFICATION AND CHARACTERIZATION OF DRIVER GENE(S) IN RECURRENT LUNG CANCER AM 5R01CA127547-02 2008-09-08 2009-08-01 31-Jul-10 2009 MU, DAVID PENNSYLVANIA STATE UNIV HERSHEY MED CTR HERSHEY PA UNITED STATES NCI $289,649 Biotechnology;Cancer;Genetics;Lung;Lung Cancer
DETERMINANTS AND RISKS OF USE AND OVERUSE OF EXPENSIVE ONCOLOGY DRUGS 5R01CA134964-02 2008-09-12 2009-08-01 31-Jul-10 2009 HERSHMAN, DAWN COLUMBIA UNIVERSITY HEALTH SCIENCES NEW YORK NY UNITED STATES NCI $259,686 Aging;Breast Cancer;Cancer;Clinical Research;Health Disparities;Health Services;Hematology;Minority Health;Orphan Drug;Prostate Cancer;Urologic Diseases
DISSECTING MECHANISMS OF METASTASIS THROUGH COMPARATIVE SYSTEMS GENETICS 5R01CA138265-02 2008-09-25 2009-08-01 31-Jul-10 2009 KIRSCH, DAVID G DUKE UNIVERSITY DURHAM NC UNITED STATES NCI $483,906 Biotechnology;Breast Cancer;Cancer;Genetics;Human Genome
OPENING THE BLOOD BRAIN BARRIER FOR MOLECULAR IMAGING 5U41RR019703-05 2009-08-01 2009-08-01 31-Jul-10 2009 HYNYNEN, KULLERVO BRIGHAM AND WOMEN'S HOSPITAL BOSTON MA UNITED STATES NCRR $54,793 Bioengineering;Biotechnology;Brain Cancer;Brain Disorders;Breast Cancer;Cancer;Diagnostic Radiology;Nanotechnology;Neurosciences
HER-2/IGF-IR CROSS-TALK AND HERCEPTIN RESISTANCE 3K01CA118174-05S1 2009-08-01 2009-08-01 31-Jul-11 2009 NAHTA, RITA EMORY UNIVERSITY ATLANTA GA UNITED STATES NCI $109,620 Bioengineering;Biotechnology;Breast Cancer;Cancer;Nanotechnology
GROWTH FACTOR RECEPTOR SIGNALING IN BREAST CANCER 3P01CA099031-05S1 2009-08-01 2009-08-01 31-Jul-10 2009 HUNG, MIEN-CHIE UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $151,419 Breast Cancer;Cancer;Clinical Research
RESEARCH PROGRAMS-SIGNAL TRANSDUCTION 5P30CA016359-31 2009-08-01 31-Jul-10 2009 SCHLESSINGER, JOSEPH YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $27,152 Breast Cancer;Cancer
BREAST CANCER VACCINE STRATEGIES FOR HER2-OVEREXPRESSING AND LUM. B TUMORS 5P50CA058223-17 2009-08-01 31-Jul-10 2009 SERODY, JONATHAN STUART UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCI $223,827 Biotechnology;Breast Cancer;Cancer;Immunization;Infectious Diseases;Prevention;Vaccine Related;Vector-Borne Diseases
SPORE CORE 1: ADMINISTRATIVE, EVALUATION AND PLANNING 5P50CA093683-07 2009-08-01 31-Jul-10 2009 MARASCO, WAYNE A. BRIGHAM AND WOMEN'S HOSPITAL BOSTON MA UNITED STATES NCI $279,688 Biotechnology;Cancer;Immunization;Lymphoma;Prevention;Vaccine Related
OPTIMAL PREDICTORS OF RESPONSE TO TRASTUZUMAB 1R01CA139431-01 2009-08-05 2009-08-05 31-Jul-10 2009 RIMM, DAVID L YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $587,922 Biotechnology;Breast Cancer;Cancer;Genetics
RACIAL/ETHNIC AND SES DISPARITIES IN QUALITY OF BREAST CANCER SYSTEMIC THERAPY 1R01CA139014-01 2009-08-11 2009-08-11 31-Jul-10 2009 GRIGGS, JENNIFER J UNIVERSITY OF MICHIGAN AT ANN ARBOR ANN ARBOR MI UNITED STATES NCI $560,091 Behavioral and Social Science;Breast Cancer;Cancer
THE ROLE OF T-DARPP IN ESOPHAGEAL ADENOCARCINOMA 1R01CA133738-01A2 2009-08-13 2009-08-13 31-Jul-10 2009 EL-RIFAI, WAEL VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $232,500 Biotechnology;Cancer;Digestive Diseases
PROGNOSTIC AND PREDICTIVE GENE SETS IN HER2-POSITIVE BREAST CANCER:THE HERA TRIAL 1R21CA139428-01 2009-08-21 2009-08-21 31-Jul-10 2009 LEYLAND-JONES, BRIAN EMORY UNIVERSITY ATLANTA GA UNITED STATES NCI $214,103 Breast Cancer;Cancer;Genetics
TARGETING SIGNALING NETWORKS VIA NOVEL RNAI APPROACHES TO IMPROVE THERAPY FOR O 2P50CA083638-11 2009-08-21 2009-08-21 31-May-10 2009 GODWIN, ANDREW K FOX CHASE CANCER CENTER PHILADELPHIA PA UNITED STATES NCI $275,341 Biotechnology;Cancer;Clinical Research;Genetics;Orphan Drug;Ovarian Cancer
PHASE I TRIAL WITH TWO HER-2 B CELL EPITOPE VACCINE IN PATIENTS WITH SOLID TUMORS 1R21CA135608-01A2 2009-08-25 2009-08-25 31-Jul-10 2009 KAUMAYA, PRAVIN T.P OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $330,000 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Immunization;Lung;Lung Cancer;Prevention;Vaccine Related
PROFILING ER, PR, EGFR AND HER2 IN BREAST CANCER USING MULTIPLEX TISSUE IMMUSTA 5R44CA123994-03 2006-08-01 2009-08-27 31-Jul-10 2009 JAMES, WILLIAM M 20/20 GENESYSTEMS, INC. ROCKVILLE MD UNITED STATES NCI $106,461 Bioengineering;Biotechnology;Breast Cancer;Cancer
REWIRING ERBB SIGNALING IN CANCER CELLS 5R01CA098881-07 2003-07-01 2009-08-31 31-Jul-10 2009 LANDGRAF, RALF UNIVERSITY OF MIAMI SCHOOL OF MEDICINE MIAMI FL UNITED STATES NCI $273,042 Breast Cancer;Cancer
TWO COMPARTMENT MODELS TO IMPROVE BRAIN TUMOR THERAPY 5R01CA137488-15 1995-08-15 2009-09-01 31-Aug-10 2009 NEUWELT, EDWARD A OREGON HEALTH AND SCIENCE UNIVERSITY PORTLAND OR UNITED STATES NCI $495,178 Brain Cancer;Brain Disorders;Breast Cancer;Cancer;Clinical Research;Lymphoma;Neurosciences;Orphan Drug
TWO COMPARTMENT MODELS TO IMPROVE BRAIN TUMOR THERAPY 3R01CA137488-15S1 1995-08-15 2009-09-01 31-Aug-11 2009 NEUWELT, EDWARD A OREGON HEALTH AND SCIENCE UNIVERSITY PORTLAND OR UNITED STATES NCI $1,969,722 Brain Cancer;Brain Disorders;Breast Cancer;Cancer;Clinical Research;Lymphoma;Neurosciences;Orphan Drug
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 3P50CA089393-10S1 2000-09-30 2009-09-01 31-Aug-11 2009 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $238,958 No NIH Category available.
DANA-FARBER/HARVARD SPORE IN BREAST CANCER 5P50CA089393-10 2000-09-30 2009-09-01 31-Aug-11 2009 IGLEHART, JAMES DIRK DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $2,179,546 No NIH Category available.
INNATE IMMUNITY: ELUCIDATION AND MODULATION FOR CANCER THERAPY 5P01CA095426-08 2002-02-01 2009-09-01 31-Aug-10 2009 CALIGIURI, MICHAEL A OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $2,044,559 No NIH Category available.
PHARMACODYNAMIC ASSESSMENT OF RTK INHIBITORS IN CANCER 7R01CA112385-06 2005-02-23 2009-09-01 31-Jan-11 2009 HALLAHAN, DENNIS E WASHINGTON UNIVERSITY SAINT LOUIS MO UNITED STATES NCI $186,770 Cancer;Diagnostic Radiology;Lung;Lung Cancer;Orphan Drug
UTMDACC SPORE IN BREAST CANCER 5P50CA116199-05 2005-09-23 2009-09-01 31-Aug-11 2009 HORTOBAGYI, GABRIEL N UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $2,180,817 No NIH Category available.
REGULATION OF HER2/NEU BY ACTIVATION LOOP PHOSPHORYLATION AND ALG-2 5K22CA128951-03 2007-09-18 2009-09-01 31-Aug-10 2009 BOSE, RON WASHINGTON UNIVERSITY SAINT LOUIS MO UNITED STATES NCI $149,163 Biotechnology;Breast Cancer;Cancer;Genetics
PERSONALIZED MEDICINE FOR COLORECTAL AND BREAST CANCER 5P01CA130818-02 2008-09-16 2009-09-01 31-Aug-10 2009 PHILLIPS, KATHRYN A UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $1,789,311 No NIH Category available.
STRUCTURE-BASED PREDICTION OF THE INTERACTOME 3R01GM081871-02S1 2009-09-01 2009-09-01 31-Aug-11 2009 BERGER, BONNIE MASSACHUSETTS INSTITUTE OF TECHNOLOGY CAMBRIDGE MA UNITED STATES NIGMS $289,931 Bioengineering;Biotechnology;Genetics;Human Genome;Networking and Information Technology R&D
MEASUREMENT IN DIVERSE POPULATIONS 5P01CA130818-02 2009-09-01 31-Aug-10 2009 PONCE, NINEZ ALAFRIZ UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $96,651 Bioengineering;Breast Cancer;Cancer
TARGETED COMBINATIONS FOR HER2- POSITIVE BREAST CANCER BIOLOGY 5P50CA089393-10 2009-09-01 31-Aug-10 2009 HARRIS, LYNDSAY N DANA-FARBER CANCER INSTITUTE BOSTON MA UNITED STATES NCI $137,947 Breast Cancer;Cancer
NONINVASIVE ASSESSMENT OF CANCER RESPONSIVENESS TO THERAPY BY USE OF ..... 5P50CA128323-02 2009-09-01 31-Aug-10 2009 HALLAHAN, DENNIS E VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $163,107 Cancer;Diagnostic Radiology
MOUSE MODELING AND ANIMAL DEVELOPMENT 5P01CA095426-08 2009-09-01 31-Aug-10 2009 MUTHUSAMY, NATARAJAN OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $247,666 Biotechnology;Cancer;Genetics;Lymphoma
KINASE IMAGING 5P50CA086355-10 2009-09-01 31-Aug-10 2009 JOSEPHSON, LEE MASSACHUSETTS GENERAL HOSPITAL BOSTON MA UNITED STATES NCI $252,886 Bioengineering;Biotechnology;Cancer;Diagnostic Radiology;Nanotechnology
PTEN DEFICIENCY AND TRASTUZUMAB RESISTANCE 5P50CA116199-05 2009-09-01 31-Aug-10 2009 YU, DIHUA UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $269,341 Breast Cancer;Cancer;Clinical Research
ECONOMICS OF PERSONALIZED MEDICINE USING GENOMICS 5P01CA130818-02 2009-09-01 31-Aug-10 2009 LADABAUM, URI UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $281,717 Bioengineering;Breast Cancer;Cancer;Clinical Research;Cost Effectiveness Research;Health Services;Prevention
HSP90 AS A TARGET FOR MECHANISM-BASED THERAPY FOR CASTRATION-RESISTANT PROSTATE C 5P50CA092629-09 2009-09-01 31-Aug-10 2009 ROSEN, NEAL SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $362,472 Aging;Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Prostate Cancer;Urologic Diseases
MULTIPLEXED NANOPARTICLE PROBES FOR THERAPEUTIC TRANSLATIONAL ONCOLOGY 5U54CA119338-05 2009-09-01 31-Aug-10 2009 SIMONS, JONATHAN W EMORY UNIVERSITY ATLANTA GA UNITED STATES NCI $379,473 Aging;Bioengineering;Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Colo-Rectal Cancer;Digestive Diseases;Gene Therapy;Genetics;Lung;Lung Cancer;Nanotechnology
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21 5P01CA095426-08 2009-09-01 31-Aug-10 2009 CARSON, WILLIAM E. OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $408,328 Breast Cancer;Cancer;Immunization
COMBINATORIAL LIBRARY SCREENING CORE 5U54CA119343-05 2009-09-01 31-Aug-10 2009 LIU, RIHE UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCI $457,370 Bioengineering;Biotechnology;Cancer;Nanotechnology;Prevention
MULTIFUNCTIONAL NANOSTRUCTURES FOR THERAPEUTIC TARGETING OF BREAST CANCER 5U54CA119341-05 2009-09-01 31-Aug-10 2009 STUPP, SAMUEL I NORTHWESTERN UNIVERSITY CHICAGO IL UNITED STATES NCI $594,551 Bioengineering;Biotechnology;Breast Cancer;Cancer;Nanotechnology
UTILIZATION OF PERSONALIZED MEDICINE USING GENOMICS 5P01CA130818-02 2009-09-01 31-Aug-10 2009 HAAS, JENNIFER S UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $742,378 Bioengineering;Biotechnology;Breast Cancer;Cancer;Clinical Research;Genetics;Health Services
THE AGING GUT: REGULATION OF CELL PROLIFERATION 3R01AG014343-12S1 2009-09-15 2009-09-15 31-Aug-11 2009 MAJUMDAR, ADHIP N. WAYNE STATE UNIVERSITY DETROIT MI UNITED STATES NIA $138,482 Aging;Cancer;Digestive Diseases
BIOLOGIC AND THERAPEUTIC IMPLICATIONS OF AKT ACTIVATION IN HER2+ BREAST CANCER 1K08CA134833-01A1 2009-09-21 2009-09-21 31-Aug-10 2009 CHANDARLAPATY, SARAT SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $145,152 Biotechnology;Breast Cancer;Cancer;Clinical Research;Genetics
BIFUNCTIONAL T CELL RECEPTOR BASED IMMUNOTHERAPEUTICS 2R44CA097550-05A1 2002-07-26 2009-09-22 31-Aug-10 2009 WONG, HING C. ALTOR BIOSCIENCE CORPORATION MIRAMAR FL UNITED STATES NCI $1,000,000 Cancer;Clinical Research;Clinical Trials;Orphan Drug
ONCOLOGY R&D: EXPANDING THE ROLE OF ECONOMICS TO AID PUBLIC POLICY 1K07CA138906-01A1 2009-09-23 2009-09-23 31-Aug-10 2009 CONTI, RENA MARIE UNIVERSITY OF CHICAGO CHICAGO IL UNITED STATES NCI $130,837 Basic Behavioral and Social Science;Behavioral and Social Science;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Cost Effectiveness Research
TARGETED THERAPIES IN BREAST CANCER 1K23CA127469-01A2 2009-09-24 2009-09-24 31-Aug-10 2009 MAYER, INGRID VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $163,944 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Genetics
MOLECULAR MAMMOGRAPHY OF HER-2 CANCERS USING GOLD NANOPARTICLES 3R44CA124190-03S1 2006-07-01 2009-09-28 31-Aug-11 2009 HAINFELD, JAMES F. NANOPROBES, INC. YAPHANK NY UNITED STATES NCI $295,393 Bioengineering;Biotechnology;Breast Cancer;Cancer;Diagnostic Radiology;Nanotechnology
FUNCTIONAL OPTICAL COHERENCE TOMOGRAPHY FOR MONITORING DRUG RESISTANCE IN CANCER 1K99CA142888-01 2009-09-28 2009-09-28 30-Jun-10 2009 SKALA, MELISSA CAROLINE DUKE UNIVERSITY DURHAM NC UNITED STATES NCI $88,596 Bioengineering;Breast Cancer;Cancer;Diagnostic Radiology;Nanotechnology
HEAT SHOCK PROTEINS IN SIGNALING AND CANCER 2R01CA081244-11A2 2000-05-01 2009-09-29 31-Aug-10 2009 SHERMAN, MICHAEL Y BOSTON UNIVERSITY MEDICAL CAMPUS BOSTON MA UNITED STATES NCI $355,597 Biotechnology;Breast Cancer;Cancer;Prevention
DEVELOPMENT OF NOVEL IMMUNOCONJUGATES FOR APPLICATION IN CANCER THERAPEUTICS 1F32CA144213-01 2009-09-30 2009-09-30 29-Sep-10 2009 YOUNG, DOUGLAS DEAN SCRIPPS RESEARCH INSTITUTE LA JOLLA CA UNITED STATES NCI $45,218 Biotechnology;Cancer
DEVELOPMENT OF TARGETED THERAPY FOR ERK PATHWAY IN BREAST CANCER 1K99CA139006-01A1 2009-09-30 2009-09-30 31-Aug-10 2009 BARTHOLOMEUSZ, CHANDRA UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $114,575 Biotechnology;Breast Cancer;Cancer
REGULATION OF STAT3 SIGNALING 3R01CA122910-03S1 2009-09-30 2009-09-30 29-Sep-11 2009 REICH, NANCY C. STATE UNIVERSITY NEW YORK STONY BROOK STONY BROOK NY UNITED STATES NCI $171,293 Cancer;Genetics;Hematology
TSG101 - A MODULATOR OF ERBB2 SIGNALING IN BREAST CANCER 3R01CA093797-06A2S1 2009-09-30 2009-09-30 29-Sep-11 2009 WAGNER, KAY-UWE UNIVERSITY OF NEBRASKA MEDICAL CENTER OMAHA NE UNITED STATES NCI $197,273 Breast Cancer;Cancer
GENE TARGETED THERAPY OF BRAIN TUMORS 1R21NS067975-01 2009-09-30 2009-09-30 31-Aug-10 2009 SAMPSON, JOHN H DUKE UNIVERSITY DURHAM NC UNITED STATES NINDS $233,754 Biotechnology;Brain Cancer;Brain Disorders;Cancer;Genetics;Human Genome;Neurosciences;Orphan Drug
ERBB RECEPTOR HOMO- AND HETERO-DIMERIZATION 3R01CA079992-11S1 2009-09-30 2009-09-30 29-Sep-11 2009 LEMMON, MARK A. UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA UNITED STATES NCI $427,626 Breast Cancer;Cancer
A NOVEL THERAPY FOR HER2 POSITIVE HORMONE REFRACTORY BREAST CANCER 1RC1CA145066-01 2009-09-30 2009-09-30 31-Aug-10 2009 HAMBURGER, ANNE W UNIVERSITY OF MARYLAND BALTIMORE BALTIMORE MD UNITED STATES NCI $467,753 Breast Cancer;Cancer;Genetics
THE MOLECULAR BASIS OF PREGNANCY-ASSOCIATED PROTECTION FROM BREAST CANCER 1RC2CA148507-01 2009-09-30 2009-09-30 31-Aug-10 2009 HANNON, GREGORY J COLD SPRING HARBOR LABORATORY COLD SPRING HARBOR NY UNITED STATES NCI $1,464,539 Breast Cancer;Cancer;Clinical Research;Estrogen;Genetics;Human Genome;Stem Cell Research;Stem Cell Research - Nonembryonic - Human
STOCHASTIC CONTROL OF ABNORMAL MORPHOGENESIS INDUCED BY THE ERBB2 ONCOPROTEIN 1DP2OD006464-01 2009-09-30 2009-09-30 31-Aug-14 2009 JANES, KEVIN A. UNIVERSITY OF VIRGINIA CHARLOTTESVILLE CHARLOTTESVILLE VA UNITED STATES OD $2,310,000 No NIH Category available.
THE MOLECULAR BASIS OF PREGNANCY-ASSOCIATED PROTECTION FROM BREAST CANCER 1RC2CA148507-01 2009-09-30 2009-09-30 31-Aug-10 2009 HANNON, GREGORY J COLD SPRING HARBOR LABORATORY COLD SPRING HARBOR NY UNITED STATES NCI Breast Cancer;Cancer;Clinical Research;Estrogen;Genetics;Human Genome;Stem Cell Research;Stem Cell Research - Nonembryonic - Human
ROLE OF EPHA2 RTK IN TUMOR RESISTANCE TO EGFR/HER2 INHIBITORS 1I01BX000134-01A1 2009-10-01 2009-10-01 30-Sep-10 2009 CHEN, JIN VETERANS HEALTH ADMINISTRATION NASHVILLE TN UNITED STATES VA No NIH Category available.
SIGNALING BY NEUREGULINS AND ERBB4 IN BREAST CANCER 5R01CA080065-10 1999-07-01 2009-12-01 30-Nov-10 2010 STERN, DAVID F YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $391,179 Breast Cancer;Cancer;Lung;Lung Cancer
BRK SIGNALS TO ERK5 IN BREAST CANCER 3R01CA107547-04S1 2006-12-15 2009-12-01 30-Nov-10 2010 LANGE, CAROL ANN UNIVERSITY OF MINNESOTA TWIN CITIES MINNEAPOLIS MN UNITED STATES NCI $47,822 Breast Cancer;Cancer
BRK SIGNALS TO ERK5 IN BREAST CANCER 5R01CA107547-04 2006-12-15 2009-12-01 30-Nov-10 2010 LANGE, CAROL ANN UNIVERSITY OF MINNESOTA TWIN CITIES MINNEAPOLIS MN UNITED STATES NCI $249,257 Breast Cancer;Cancer
NOVEL TREATMENT OF NF-1 ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS 5R01CA122804-03 2007-12-07 2009-12-01 30-Nov-10 2010 CARROLL, STEVEN L UNIVERSITY OF ALABAMA AT BIRMINGHAM BIRMINGHAM AL UNITED STATES NCI $300,875 Cancer;Neurofibromatosis;Neurosciences
PROSPECTIVE VALIDATION OF GENOMIC SIGNATURES OF CHEMOSENSITIVITY IN NSCLC 5R01CA131049-02 2009-01-01 2009-12-01 30-Nov-10 2010 WILLARD, HUNTINGTON DUKE UNIVERSITY DURHAM NC UNITED STATES NCI $323,166 Biotechnology;Cancer;Clinical Research;Genetics;Lung;Lung Cancer
NOVARTIS CAUY922A2101: A PHASE I DOSE ESCALATION, MULTI-CENTER, OPEN-LABEL STUDY 5M01RR000865-37 2009-12-01 2009-12-01 30-Nov-10 2010 BRITTEN, CAROLYN D UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCRR $659 Breast Cancer;Cancer;Clinical Research
WOMEN'S CANCERS 5P30CA016042-35 2009-12-01 30-Nov-10 2010 GLASPY, JOHN A UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $69,664 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Genetics;Nutrition;Prevention
TARGETING THE HER2 PATHWAY: MECHANISMS OF RESISTANCE & STRATEGIES TO OVERCOME 5P50CA058183-16 2009-12-01 30-Nov-10 2010 OSBORNE, C KENT BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $249,997 Antimicrobial Resistance;Breast Cancer;Cancer;Infectious Diseases
PROTOCOL SPECIFIC RESEARCH 5P30CA033572-27 2009-12-01 30-Nov-10 2010 KRONTIRIS, THEODORE G CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $317,892 Brain Cancer;Brain Disorders;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Hematology;Orphan Drug
SENIOR LEADERS 5P30CA016042-35 2009-12-01 30-Nov-10 2010 GASSON, JUDITH CHERYL UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $777,779 Cancer;Health Disparities
HER3 SIGNALING IN DEVELOPMENT AND CANCER OF THE BREAST 1R01CA143126-01 2009-12-09 2009-12-09 30-Nov-10 2010 COOK, REBECCA SARA VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $321,625 Breast Cancer;Cancer
TRANSLATIONAL RESEARCH IN BREAST CANCER 5P50CA058183-16 1992-09-30 2009-12-11 30-Nov-10 2010 OSBORNE, C KENT BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $2,300,000 No NIH Category available.
DETERMINANTS OF TUMOR SENSITIVITY TO EGFR-TARGETED ANTIBODIES 5R01CA050633-20 1989-06-01 2010-01-01 31-Dec-10 2010 WEINER, LOUIS M GEORGETOWN UNIVERSITY WASHINGTON DC UNITED STATES NCI $330,858 Biotechnology;Cancer;Genetics;HIV/AIDS;Immunization
ERBB RECEPTOR HOMO- AND HETERO-DIMERIZATION 5R01CA079992-12 1999-02-01 2010-01-01 31-Dec-10 2010 LEMMON, MARK A. UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA UNITED STATES NCI $255,723 Breast Cancer;Cancer
TSG101 - A MODULATOR OF ERBB2 SIGNALING IN BREAST CANCER 5R01CA093797-07 2002-01-01 2010-01-01 31-Dec-10 2010 WAGNER, KAY-UWE UNIVERSITY OF NEBRASKA MEDICAL CENTER OMAHA NE UNITED STATES NCI $265,863 Breast Cancer;Cancer
THE BIOLOGY OF AGGRESSIVE BREAST CANCER: MINING THE TRIPLE NEGATIVE TRANSCRIPTOME 1F32CA145054-01 2010-01-01 2010-01-01 31-Dec-11 2009 STRICKER, THOMAS PAUL UNIVERSITY OF CHICAGO CHICAGO IL UNITED STATES NCI $53,354 Biotechnology;Breast Cancer;Cancer;Genetics;Human Genome
TARGETING JAB1 ONCOGENIC FUNCTION IN BREAST CANCER 5R01CA090853-09 2001-04-01 2010-02-01 31-Jan-11 2010 CLARET, FRANCOIS X UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $255,009 Biotechnology;Breast Cancer;Cancer;Genetics
THE ROLE OF SYNDECAN-1 IN MOUSE MAMMARY NEOPLASIA 5R01CA090877-08 2001-04-01 2010-02-01 31-Jan-11 2010 ALEXANDER, CAROLINE MARGARET UNIVERSITY OF WISCONSIN MADISON MADISON WI UNITED STATES NCI $295,173 Breast Cancer;Cancer;Stem Cell Research;Stem Cell Research - Nonembryonic - Non-Human
NSABP PARTICIPATING SITES 5U10CA118735-05 2006-04-10 2010-02-01 31-Jan-11 2010 CHANG, JENNY C-N BAYLOR COLLEGE OF MEDICINE HOUSTON TX UNITED STATES NCI $53,618 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Health Disparities;Minority Health
REGULATION OF STAT3 SIGNALING 5R01CA122910-04 2007-04-01 2010-02-01 31-Jan-12 2010 REICH, NANCY C. STATE UNIVERSITY NEW YORK STONY BROOK STONY BROOK NY UNITED STATES NCI $294,500 Cancer;Genetics;Hematology
CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING 5R44CA130026-03 2007-09-28 2010-02-01 31-Jan-11 2010 HOYT, CLIFFORD C CAMBRIDGE RESEARCH AND INSTRUMENTATION WOBURN MA UNITED STATES NCI $913,767 Bioengineering;Biotechnology;Cancer
PREDICTION OF NEOADJUVANT CHEMO PATHOLOGICAL RESPONSE USING MRI MARKERS 5R01CA127927-03 2008-04-01 2010-02-01 31-Jan-11 2010 SU, MIN-YING L UNIVERSITY OF CALIFORNIA IRVINE IRVINE CA UNITED STATES NCI $511,095 Breast Cancer;Cancer;Clinical Research;Diagnostic Radiology
MECHANISMS OF TUMOR RESISTANCE TO ANTI-HER/ERBB THERAPEUTICS 5R01CA129036-03 2008-04-02 2010-02-01 31-Jan-11 2010 FAN, ZHEN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $319,550 Biotechnology;Breast Cancer;Cancer;Hematology
MOLECULAR BASIS OF GENOMIC INSTABILITY IN AGGRESSIVE BASAL-LIKE BREAST CANCER 1F32CA144402-01 2010-02-01 2010-02-01 31-Jan-11 2009 HOLCOMB, ILONA NOELANI STANFORD UNIVERSITY STANFORD CA UNITED STATES NCI $50,054 Biotechnology;Breast Cancer;Cancer;Genetics
REGULATION OF BASAL-LIKE AND HER2+ BREAST CANCER PHENOTYPES BY IKK/NF-KAPPAB 1R01CA138937-01A1 2010-02-01 2010-02-01 31-Dec-10 2010 BALDWIN, ALBERT SIDNEY UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCI $305,763 Aging;Biotechnology;Breast Cancer;Cancer;Genetics
SMALL MOLECULE INHIBITORS OF THE TRANSCRIPTIONAL ACTIVATORS ESX AND NF-KB 5R01CA140667-02 2009-05-20 2010-03-01 28-Feb-11 2010 MAPP, ANNA K. UNIVERSITY OF MICHIGAN AT ANN ARBOR ANN ARBOR MI UNITED STATES NCI $305,815 Breast Cancer;Cancer;Genetics
PREDICTION OF CHEMOTHERAPY INDUCED CARDIOMYOPATHY WITH MRI DETECT I 5M01RR007122-19 2010-03-01 2010-03-01 28-Feb-11 2010 HUNDLEY, WILLIAM GREGORY WAKE FOREST UNIVERSITY HEALTH SCIENCES WINSTON-SALEM NC UNITED STATES NCRR $58,848 Cancer;Cardiovascular;Clinical Research;Diagnostic Radiology;Heart Disease;Heart Disease - Coronary Heart Disease
TAKE HEART: EXERCISE & DIET INTERVENTION FOR HEART FAILURE IN CANCER SURVIVORS 5R21CA135016-02 2009-03-13 2010-03-08 28-Feb-11 2010 BASEN-ENGQUIST, KAREN M UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $203,280 Behavioral and Social Science;Cancer;Cardiovascular;Clinical Research;Heart Disease;Mind and Body;Nutrition;Prevention;Rehabilitation
PSK AS NEOADJUVANT THERAPY FOR LOCALLY ADVANCED BREAST CANCER 1R01CA138547-01A1 2010-03-08 2010-03-08 31-Dec-10 2010 LU, HAILING UNIVERSITY OF WASHINGTON SEATTLE WA UNITED STATES NCI $287,877 Breast Cancer;Cancer;Complementary and Alternative Medicine
QUANTITATIVE ANALYSIS OF RET RECEPTOR ACTIVATION AND SIGNALING 1R01GM087469-01A2 2010-03-10 2010-03-10 31-Jan-11 2010 WHITTY, ADRIAN BOSTON UNIVERSITY BOSTON MA UNITED STATES NIGMS $289,750 Neurosciences
TARGETING THE IGF SYSTEM IN BREAST CANCER 5R01CA074285-13 1998-01-01 2010-03-11 28-Feb-11 2010 YEE, DOUGLAS UNIVERSITY OF MINNESOTA TWIN CITIES MINNEAPOLIS MN UNITED STATES NCI $354,113 Breast Cancer;Cancer
MULTIFUNCTIONAL NANOPARTICLES FOR TARGETING ABERRANT TUMORIGENIC PATHWAYS 1R01CA135242-01A2 2010-03-19 2010-03-19 31-Dec-10 2010 SENGUPTA, SHILADITYA BRIGHAM AND WOMEN'S HOSPITAL BOSTON MA UNITED STATES NCI $369,350 Bioengineering;Cancer;Nanotechnology
REGULATION OF ERBB2/NEU-INDUCED MAMMARY GLAND CANCER 5R01CA090398-09 2001-03-05 2010-03-30 31-Jan-11 2010 KERI, RUTH A CASE WESTERN RESERVE UNIVERSITY CLEVELAND OH UNITED STATES NCI $211,288 Breast Cancer;Cancer;Clinical Research;Genetics
EARLY SCREENING OF BREAST LESION TRIAL (PHASE III PIVOTAL) 5R44CA126441-04 2007-09-27 2010-03-30 28-Feb-11 2010 BENARON, DAVID A. SPECTROS CORPORATION Portola Valley CA UNITED STATES NCI $581,183 Bioengineering;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Diagnostic Radiology;Prevention;Prostate Cancer;Urologic Diseases
BRAIN TUMORS - IMMUNOLOGICAL AND BIOLOGICAL STUDIES 5R37CA011898-40 1976-12-01 2010-04-01 31-Mar-11 2010 BIGNER, DARELL D DUKE UNIVERSITY DURHAM NC UNITED STATES NCI $703,967 Brain Cancer;Brain Disorders;Cancer;Neurosciences;Orphan Drug
ERBB2 TARGETED ANTITUMOR STRATEGIES IN BREAST CANCER 2R01CA080195-10A2 1999-01-01 2010-04-01 31-Jan-11 2010 ARTEAGA, CARLOS L VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $320,163 Breast Cancer;Cancer
IN VIVO ONCOGENE-INDUCED TUMORIGENESIS AND ESCAPE 2R01CA098371-06 2003-04-18 2010-04-01 31-Jan-11 2010 CHODOSH, LEWIS A UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA UNITED STATES NCI $347,135 Breast Cancer;Cancer;Genetics
STRUCTURE-BASED PREDICTION OF THE INTERACTOME 5R01GM081871-03 2008-04-01 2010-04-01 31-Mar-11 2010 BERGER, BONNIE MASSACHUSETTS INSTITUTE OF TECHNOLOGY CAMBRIDGE MA UNITED STATES NIGMS $301,191 Bioengineering;Biotechnology;Genetics;Human Genome;Networking and Information Technology R&D
RELEASABLE ANTIBODIES FOR MULTIPLEXED ANALYSIS OF CANCER BIOMARKERS 1R21CA143275-01 2010-04-01 2010-04-01 31-Mar-11 2010 SOOD, ANUP GENERAL ELECTRIC GLOBAL RESEARCH CTR NISKAYUNA NY UNITED STATES NCI $338,376 Biotechnology;Breast Cancer;Cancer
EXPLOITING BIOLOGICAL NETWORKS TO IMPROVE CLINICAL TREATMENT OF OVARIAN CANCER 1R01CA140323-01A1 2010-04-01 2010-04-01 31-Jan-11 2010 GODWIN, ANDREW K FOX CHASE CANCER CENTER PHILADELPHIA PA UNITED STATES NCI $423,060 Biotechnology;Cancer;Genetics;Orphan Drug;Ovarian Cancer
DNA METHYLATION: A MECHANISM FOR AGGRESSIVE BREAST CANCER IN AFRICAN-AMERICAN WOM 1R01CA133264-01A2 2010-04-01 2010-04-01 31-Jan-11 2010 AMBROSONE, CHRISTINE B. ROSWELL PARK CANCER INSTITUTE CORP BUFFALO NY UNITED STATES NCI $964,919 Breast Cancer;Cancer;Clinical Research;Genetics;Health Disparities;Minority Health;Prevention
PROGRAM 3 (IMMUNOLOGY AND CANCER) 5P30CA014599-35 2010-04-01 31-Mar-11 2010 GAJEWSKI, THOMAS F UNIVERSITY OF CHICAGO CHICAGO IL UNITED STATES NCI $26,979 Biotechnology;Cancer;Clinical Research;Immunization;Transplantation;Vaccine Related
HUMAN IMMUNOLOGIC MONITORING 5P30CA014599-35 2010-04-01 31-Mar-11 2010 GAJEWSKI, THOMAS F UNIVERSITY OF CHICAGO CHICAGO IL UNITED STATES NCI $139,619 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Immunization;Orphan Drug;Transplantation;Vaccine Related
ROLES OF NF-KB/REL IN THE PATHOGENESIS OF BREAST CANCER 7R01CA129129-03 2008-04-01 2010-04-08 31-Jan-11 2010 SONENSHEIN, GAIL E TUFTS UNIVERSITY BOSTON BOSTON MA UNITED STATES NCI $352,574 Breast Cancer;Cancer;Complementary and Alternative Medicine;Genetics;Nutrition
TARGETED INTERVENTION OF BREAST ONCOGENIC PATHWAYS 2R01CA098473-06A2 2003-06-13 2010-05-01 31-Mar-11 2010 SEBTI, SAID M H. LEE MOFFITT CANCER CTR & RES INST TAMPA FL UNITED STATES NCI $319,306 Biotechnology;Breast Cancer;Cancer;Clinical Research
MOLECULAR BASIS OF SLITS AS TUMOR SUPPRESSORS CONTROLLING CXCR4/SDF1 IN BREAST 3R01CA128902-03S1 2008-07-01 2010-05-01 30-Apr-11 2010 HINCK, LINDSAY E UNIVERSITY OF CALIFORNIA SANTA CRUZ SANTA CRUZ CA UNITED STATES NCI $33,328 Breast Cancer;Cancer;Genetics
MOLECULAR BASIS OF SLITS AS TUMOR SUPPRESSORS CONTROLLING CXCR4/SDF1 IN BREAST 5R01CA128902-03 2008-07-01 2010-05-01 30-Apr-11 2010 HINCK, LINDSAY E UNIVERSITY OF CALIFORNIA SANTA CRUZ SANTA CRUZ CA UNITED STATES NCI $308,832 Breast Cancer;Cancer;Genetics
NR1D1 PATHWAY IN BREAST CANCER 5R01CA136658-02 2009-06-01 2010-05-01 30-Apr-11 2010 CONKLIN, DOUGLAS S STATE UNIVERSITY OF NEW YORK AT ALBANY ALBANY NY UNITED STATES NCI $314,363 Biotechnology;Breast Cancer;Cancer;Genetics;Nutrition
THE ROLE OF AURORA KINASE A IN UPPER GASTROINTESTINAL ADENOCARCINOMAS 5R01CA131225-02 2009-06-01 2010-05-01 30-Apr-11 2010 EL-RIFAI, WAEL VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $319,343 Cancer;Digestive Diseases;Genetics
THE IMPLEMENTATION OF A PHARMACOGENOMICS-BASED ALGORITHM FOR WARFARIN DOSING 5K23HL089808-02 2009-07-15 2010-05-01 30-Apr-11 2010 PERERA, MINOLI UNIVERSITY OF CHICAGO CHICAGO IL UNITED STATES NHLBI $120,339 Clinical Research;Clinical Trials;Cost Effectiveness Research;Genetic Testing;Genetics;Health Disparities;Human Genome;Minority Health;Patient Safety
NOVEL HER2 TARGETING IMMUNOTHERAPEUTICS FOR BREAST CANCER 1R43AI081465-01A1 2010-05-01 2010-05-01 30-Apr-11 2010 JENSEN, MARK ALLEN ITERATIVE THERAPEUTICS, INC. CHICAGO IL UNITED STATES NIAID $231,045 Biotechnology;Breast Cancer;Cancer;Clinical Research
SCFV PIEZOIMMUNOSENSOR DETECTION OF THERAPEUTIC ANTIBODIES IN HUMAN SERUM 1R21EB009513-01A1 2010-05-01 2010-05-01 30-Apr-11 2010 ZENG, XIANGQUN OAKLAND UNIVERSITY ROCHESTER MI UNITED STATES NIBIB $231,627 Biotechnology;Immunization
EVALUATION AND VALIDATION OF IMAGING BIOMARKERS OF TUMOR RESPONSE TO TREATMENT 1R01CA138599-01A1 2010-05-01 2010-05-01 28-Feb-11 2010 YANKEELOV, THOMAS E VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $373,101 Breast Cancer;Cancer;Diagnostic Radiology
IMPROVING INTERSTITIAL TRANSPORT IN TUMORS 5P01CA080124-10 2010-05-01 30-Apr-11 2010 JAIN, RAKESH K. MASSACHUSETTS GENERAL HOSPITAL BOSTON MA UNITED STATES NCI $310,646 Biotechnology;Breast Cancer;Cancer;Gene Therapy;Genetics
DEVELOPMENT OF MECHANISM-BASED STRATEGIES FOR THE TREATMENT OF ADVANCED BREAST CA 5P01CA094060-08 2010-05-01 30-Apr-11 2010 ROSEN, NEAL SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $456,578 Breast Cancer;Cancer;Clinical Research
NEXT GENERATION STRATEGIES TO INTERCEPT ERBB SIGNALING 4R37CA072981-14 1997-04-25 2010-05-21 31-Mar-11 2010 YARDEN, YOSEF NONE WEIZMANN INSTITUTE OF SCIENCE REHOVOT ISRAEL NCI $237,319 Biotechnology;Breast Cancer;Cancer
THE MOLECULAR ACTIONS OF IMATINIB MESYLATE IN GISTS 5R01CA106588-07 2004-05-01 2010-06-01 31-May-11 2010 GODWIN, ANDREW K FOX CHASE CANCER CENTER PHILADELPHIA PA UNITED STATES NCI $433,446 Biotechnology;Cancer;Clinical Research;Clinical Trials;Colo-Rectal Cancer;Digestive Diseases;Genetics;Orphan Drug;Prevention
MECHANISMS OF INVERTEBRATE EGF RECEPTOR INHIBITION 5R01CA125432-04 2007-07-01 2010-06-01 31-May-11 2010 LEMMON, MARK A. UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA UNITED STATES NCI $236,655 Breast Cancer;Cancer
ERBB2 DOWNREGULATION THROUGH HSP90 INHIBITION 5R01CA116552-05 2007-08-01 2010-06-01 31-May-11 2010 BAND, HAMID UNIVERSITY OF NEBRASKA MEDICAL CENTER OMAHA NE UNITED STATES NCI $279,300 Biotechnology;Breast Cancer;Cancer
INTEGRATED BIOCHIP SENSORS FOR DETECTION OF CANCER 5R01CA120003-03 2008-07-01 2010-06-01 31-May-11 2010 BASHIR, RASHID UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN CHAMPAIGN IL UNITED STATES NCI $522,748 Bioengineering;Biotechnology;Breast Cancer;Cancer;Clinical Research;Nanotechnology
SIGNAL TRANSDUCTION IN THE HEART AFTER CANCER THERAPY 5R01HL088649-03 2008-08-01 2010-06-01 31-May-11 2010 GABRIELSON, KATHLEEN LOUISE JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NHLBI $410,000 Biotechnology;Breast Cancer;Cancer;Cardiovascular;Heart Disease
TARGETING SIGNALING NETWORKS VIA NOVEL RNAI APPROACHES TO IMPROVE THERAPY FOR O 5P50CA083638-12 2010-06-01 31-May-11 2010 GODWIN, ANDREW K FOX CHASE CANCER CENTER PHILADELPHIA PA UNITED STATES NCI $341,238 Biotechnology;Cancer;Clinical Research;Genetics;Orphan Drug;Ovarian Cancer
PREDICTIVE BIOMARKERS OF ADJUVANT TRASTUZUMAB IN THE HER2+N9831 INTERGROUP TRIAL 5R01CA129949-03 2008-05-20 2010-06-14 30-Apr-11 2010 PEREZ, EDITH ADALJISA MAYO CLINIC JACKSONVILLE JACKSONVILLE FL UNITED STATES NCI $198,218 Biotechnology;Breast Cancer;Cancer;Clinical Research;Genetics
PROTEIN TYROSINE DEPHOSPHORYLATION & SIGNAL TRANSDUCTION 2R01CA053840-19A2 1991-08-01 2010-07-01 30-Apr-11 2010 TONKS, NICHOLAS K COLD SPRING HARBOR LABORATORY COLD SPRING HARBOR NY UNITED STATES NCI $712,640 Breast Cancer;Cancer
CROSSTALK TGFBETA AND HER2 (ERBB2) SIGNALING IN MAMMARY TUMORIGENESIS 5R00CA125892-05 2007-07-25 2010-07-01 30-Jun-11 2010 WANG, SHIZHEN EMILY CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $249,000 Breast Cancer;Cancer
MONITORING BREAST CANCER CHEMOTHERAPEUTIC RESPONSE USING DOSI, MRI AND BIOMARKERS 5U54CA136400-02 2009-07-17 2010-07-01 30-Jun-11 2010 TROMBERG, BRUCE J UNIVERSITY OF CALIFORNIA IRVINE IRVINE CA UNITED STATES NCI $454,567 Bioengineering;Breast Cancer;Cancer;Clinical Research;Diagnostic Radiology
THE ROLE OF NEUREGULIN IN HUMAN CARDIAC REMODELING AND HEART FAILURE 1K23HL095661-01A1 2010-07-01 2010-07-01 30-Jun-11 2010 KY, BONNIE UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA UNITED STATES NHLBI $142,776 Cardiovascular;Clinical Research;Heart Disease;Kidney Disease
MOLECULAR PHOTOTHERMAL THERAPY OF CANCER USING TARGETED METAL NANOPARTICLES 1R01CA149740-01A1 2010-07-01 2010-07-01 31-May-11 2010 EMELIANOV, STANISLAV Y UNIVERSITY OF TEXAS AUSTIN AUSTIN TX UNITED STATES NCI $356,018 Bioengineering;Breast Cancer;Cancer;Diagnostic Radiology;Nanotechnology
DEVELOPMENTAL RESEARCH PROGRAM 5P50CA086438-10 2010-07-01 30-Jun-11 2010 JURCIC, JOSEPH G SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $159,080 Bioengineering;Biotechnology;Cancer;Clinical Research;Diagnostic Radiology;Genetics;Hematology;Lymphoma;Nanotechnology;Orphan Drug;Regenerative Medicine;Transplantation
RESEARCH PROJECT 3: ROLE OF THE NF-KB/REL IN MAMMARY CARCINOGENESIS 7P01ES011624-08 2010-07-01 30-Jun-11 2009 SONENSHEIN, GAIL E TUFTS UNIVERSITY BOSTON BOSTON MA UNITED STATES NIEHS $167,648 No NIH Category available.
MOLECULAR IMAGING OF CASTRATE- RESISTANCE METASTATIC PROSTATE CANCER 5P50CA086438-10 2010-07-01 30-Jun-11 2010 LARSON, STEVEN MARK SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $203,991 Bioengineering;Cancer;Clinical Research;Diagnostic Radiology;Nanotechnology;Prostate Cancer;Urologic Diseases
DEVELOPMENT OF METHODOLOGIES FOR THE IN VIVO IMAGING OG THE EFFECTS OF NOVEL INHI 5P50CA086438-10 2010-07-01 30-Jun-11 2010 ROSEN, NEAL SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $223,770 Bioengineering;Biotechnology;Breast Cancer;Cancer;Diagnostic Radiology
RADIOIMMUNOTHERAPY: CLINICAL STUDIES 5P01CA043904-19 2010-07-01 30-Jun-11 2010 WONG, JEFFREY Y CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $245,900 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Colo-Rectal Cancer;Digestive Diseases;Immunization;Vaccine Related
CLINICAL PRODUCTION 5P01CA043904-19 2010-07-01 30-Jun-11 2010 YAZAKI, PAUL CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $316,618 Biotechnology;Cancer;Clinical Research;Clinical Trials;Genetics
RADIOPHARMACY AND ASSAYS 5P01CA043904-19 2010-07-01 30-Jun-11 2010 COLCHER, DAVID MORRIS CITY OF HOPE/BECKMAN RESEARCH INSTITUTE DUARTE CA UNITED STATES NCI $504,135 Biotechnology;Cancer;Clinical Research;Immunization;Vaccine Related
NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT 3U10CA012027-40S1 1976-12-01 2010-07-02 30-Jun-11 2010 WOLMARK, NORMAN NSABP FOUNDATION, INC. PITTSBURGH PA UNITED STATES NCI $188,932 Breast Cancer;Cancer;Clinical Research;Clinical Trials;Colo-Rectal Cancer;Digestive Diseases;Health Disparities;Minority Health;Patient Safety
ENHANCING NEOADJUVANT CHEMOTHERPAY RESPONSES WITH TARGETED T CELLS 1R01CA140314-01A1 2010-07-09 2010-07-09 30-Apr-11 2010 LUM, LAWRENCE G WAYNE STATE UNIVERSITY DETROIT MI UNITED STATES NCI $519,027 Breast Cancer;Cancer;Clinical Research;Clinical Trials;Immunization;Stem Cell Research;Stem Cell Research - Nonembryonic - Human;Vaccine Related
ENHANCING TUMOR-TARGETED ANTIBODY THERAPY WITH A SECOND NK ACTIVATING ANTIBODY. 1R01CA153248-01 2010-07-14 2010-07-14 31-May-11 2010 LEVY, RONALD STANFORD UNIVERSITY STANFORD CA UNITED STATES NCI $267,825 Biotechnology;Breast Cancer;Cancer;Colo-Rectal Cancer;Digestive Diseases;Hematology;Immunization;Lymphoma
TARGETING HER-2 PROTEIN FOR BREAST CANCER USING COMPUTATIONAL APPROACH 2P20RR016456-09 2010-07-15 2010-07-15 30-Apr-11 2010 SATYANARAYANAJOIS, SEETHARAMA D LOUISIANA STATE UNIV A&M COL BATON ROUGE BATON ROUGE LA UNITED STATES NCRR $55,546 Breast Cancer;Cancer
NOVEL TARGETED THERAPY FOR BREAST CANCER 2R44CA124179-02A2 2006-07-16 2010-07-16 30-Jun-11 2010 SERRERO, GINETTE A AND G PHARMACEUTICAL, INC. COLUMBIA MD UNITED STATES NCI $575,793 Biotechnology;Breast Cancer;Cancer
STRUCTURAL STUDIES OF GROWTH FACTOR RECEPTOR FUNCTION 5R01CA090466-09 2001-04-01 2010-08-01 31-Jul-11 2010 LEAHY, DANIEL J JOHNS HOPKINS UNIVERSITY BALTIMORE MD UNITED STATES NCI $222,384 Breast Cancer;Cancer
BREAST CANCER TREATMENT WITH ANTIBODY TARGETED T CELLS 5R01CA092344-08 2001-07-01 2010-08-01 31-Jul-11 2010 LUM, LAWRENCE G WAYNE STATE UNIVERSITY DETROIT MI UNITED STATES NCI $501,546 Breast Cancer;Cancer;Clinical Research;Clinical Trials;Immunization;Vaccine Related
HER-2/IGF-IR CROSS-TALK AND HERCEPTIN RESISTANCE 5K01CA118174-06 2006-08-01 2010-08-01 31-Jul-11 2010 NAHTA, RITA EMORY UNIVERSITY ATLANTA GA UNITED STATES NCI $143,856 Bioengineering;Biotechnology;Breast Cancer;Cancer;Nanotechnology
MICELLE SURFACE ENGINEERING FOR ACTIVE TARGETING BY ACIDIC TUMOR EXTRACELLULAR PH 5R01CA122356-05 2006-08-22 2010-08-01 31-Jul-11 2010 BAE, YOU HAN UNIVERSITY OF UTAH SALT LAKE CITY UT UNITED STATES NCI $257,668 Bioengineering;Cancer
MUTANT EGF RECEPTOR-DEPENDENT LUNG CANCER IN HUMAN CELL LINES AND TRANSGENIC MICE 2R01CA120247-05 2006-08-22 2010-08-01 31-May-11 2010 POLITI, KATERINA ABIGAIL SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $383,570 Biotechnology;Cancer;Genetics;Lung;Lung Cancer
A NOVEL TRANSGENIC SILKWORM SYSTEM FOR RECOMBINANT GLYCOPROTEIN PRODUCTION 5R01GM080672-04 2007-09-29 2010-08-01 31-Jul-11 2010 JARVIS, DONALD L. UNIVERSITY OF WYOMING LARAMIE WY UNITED STATES NIGMS $277,307 Bioengineering;Biotechnology
BETA-CATENIN/TCF SIGNALING IN BREAST CANCER 5R01CA131219-03 2008-09-01 2010-08-01 31-Jul-11 2010 HOWE, LOUISE R WEILL MEDICAL COLLEGE OF CORNELL UNIV NEW YORK NY UNITED STATES NCI $350,675 Aging;Breast Cancer;Cancer;Prevention
IDENTIFICATION AND CHARACTERIZATION OF DRIVER GENE(S) IN RECURRENT LUNG CANCER AM 5R01CA127547-03 2008-09-08 2010-08-01 31-Jul-11 2010 MU, DAVID PENNSYLVANIA STATE UNIV HERSHEY MED CTR HERSHEY PA UNITED STATES NCI $289,649 Biotechnology;Cancer;Genetics;Lung;Lung Cancer
DETERMINANTS AND RISKS OF USE AND OVERUSE OF EXPENSIVE ONCOLOGY DRUGS 5R01CA134964-03 2008-09-12 2010-08-01 31-Jul-11 2010 HERSHMAN, DAWN COLUMBIA UNIVERSITY HEALTH SCIENCES NEW YORK NY UNITED STATES NCI $260,820 Aging;Breast Cancer;Cancer;Clinical Research;Health Disparities;Health Services;Hematology;Minority Health;Orphan Drug;Patient Safety;Prostate Cancer;Urologic Diseases
DISSECTING MECHANISMS OF METASTASIS THROUGH COMPARATIVE SYSTEMS GENETICS 5R01CA138265-03 2008-09-25 2010-08-01 31-Jul-11 2010 KIRSCH, DAVID G DUKE UNIVERSITY DURHAM NC UNITED STATES NCI $476,541 Biotechnology;Breast Cancer;Cancer;Genetics;Human Genome
OPTIMAL PREDICTORS OF RESPONSE TO TRASTUZUMAB 5R01CA139431-02 2009-08-05 2010-08-01 31-Jul-11 2010 RIMM, DAVID L YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $584,668 Biotechnology;Breast Cancer;Cancer;Genetics
RACIAL/ETHNIC AND SES DISPARITIES IN QUALITY OF BREAST CANCER SYSTEMIC THERAPY 5R01CA139014-02 2009-08-11 2010-08-01 31-Jul-11 2010 GRIGGS, JENNIFER J UNIVERSITY OF MICHIGAN AT ANN ARBOR ANN ARBOR MI UNITED STATES NCI $637,278 Behavioral and Social Science;Breast Cancer;Cancer
THE ROLE OF T-DARPP IN ESOPHAGEAL ADENOCARCINOMA 5R01CA133738-02 2009-08-13 2010-08-01 31-Jul-11 2010 EL-RIFAI, WAEL VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $232,625 Biotechnology;Cancer;Digestive Diseases
RESEARCH PROGRAMS-SIGNAL TRANSDUCTION 5P30CA016359-32 2010-08-01 31-Jul-11 2010 SCHLESSINGER, JOSEPH YALE UNIVERSITY NEW HAVEN CT UNITED STATES NCI $29,995 Breast Cancer;Cancer
BREAST CANCER VACCINE STRATEGIES FOR HER2-OVEREXPRESSING AND LUM. B TUMORS 5P50CA058223-18 2010-08-01 31-Jul-11 2010 SERODY, JONATHAN STUART UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCI $223,540 Biotechnology;Breast Cancer;Cancer;Immunization;Infectious Diseases;Prevention;Vaccine Related;Vector-Borne Diseases
SPORE CORE 1: ADMINISTRATIVE, EVALUATION AND PLANNING 5P50CA093683-08 2010-08-01 31-Jul-11 2010 MARASCO, WAYNE A. BRIGHAM AND WOMEN'S HOSPITAL BOSTON MA UNITED STATES NCI $280,414 Biotechnology;Cancer;Immunization;Lymphoma;Prevention;Vaccine Related
REWIRING ERBB SIGNALING IN CANCER CELLS 5R01CA098881-08 2003-07-01 2010-08-20 31-Jul-11 2010 LANDGRAF, RALF UNIVERSITY OF MIAMI SCHOOL OF MEDICINE MIAMI FL UNITED STATES NCI $47,678 Breast Cancer;Cancer
TWO COMPARTMENT MODELS TO IMPROVE BRAIN TUMOR THERAPY 5R01CA137488-16 1995-08-15 2010-09-01 31-Aug-11 2010 NEUWELT, EDWARD A OREGON HEALTH AND SCIENCE UNIVERSITY PORTLAND OR UNITED STATES NCI $490,363 Brain Cancer;Brain Disorders;Breast Cancer;Cancer;Clinical Research;Lymphoma;Neurosciences;Orphan Drug
HEAT SHOCK PROTEINS IN SIGNALING AND CANCER 5R01CA081244-12 2000-05-01 2010-09-01 31-Aug-11 2010 SHERMAN, MICHAEL Y BOSTON UNIVERSITY MEDICAL CAMPUS BOSTON MA UNITED STATES NCI $355,597 Biotechnology;Breast Cancer;Cancer;Prevention
BIFUNCTIONAL T CELL RECEPTOR BASED IMMUNOTHERAPEUTICS 5R44CA097550-06 2002-07-26 2010-09-01 31-Aug-11 2010 WONG, HING C. ALTOR BIOSCIENCE CORPORATION MIRAMAR FL UNITED STATES NCI $990,016 Cancer;Clinical Research;Orphan Drug
PERSONALIZED MEDICINE FOR COLORECTAL AND BREAST CANCER 5P01CA130818-03 2008-09-16 2010-09-01 31-Aug-11 2010 PHILLIPS, KATHRYN A UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $1,495,702 No NIH Category available.
BIOLOGIC AND THERAPEUTIC IMPLICATIONS OF AKT ACTIVATION IN HER2+ BREAST CANCER 5K08CA134833-02 2009-09-21 2010-09-01 31-Aug-11 2010 CHANDARLAPATY, SARAT SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $145,152 Biotechnology;Breast Cancer;Cancer;Clinical Research;Genetics
ONCOLOGY R&D: EXPANDING THE ROLE OF ECONOMICS TO AID PUBLIC POLICY 5K07CA138906-02 2009-09-23 2010-09-01 31-Aug-11 2010 CONTI, RENA MARIE UNIVERSITY OF CHICAGO CHICAGO IL UNITED STATES NCI $133,790 Basic Behavioral and Social Science;Behavioral and Social Science;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Comparative Effectiveness Research;Cost Effectiveness Research
TARGETED THERAPIES IN BREAST CANCER 5K23CA127469-02 2009-09-24 2010-09-01 31-Aug-11 2010 MAYER, INGRID VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $163,944 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Genetics
GENE TARGETED THERAPY OF BRAIN TUMORS 5R21NS067975-02 2009-09-30 2010-09-01 31-Aug-11 2010 SAMPSON, JOHN H DUKE UNIVERSITY DURHAM NC UNITED STATES NINDS $194,754 Biotechnology;Brain Cancer;Brain Disorders;Cancer;Genetics;Human Genome;Neurosciences;Orphan Drug
A NOVEL THERAPY FOR HER2 POSITIVE HORMONE REFRACTORY BREAST CANCER 5RC1CA145066-02 2009-09-30 2010-09-01 31-Aug-11 2010 HAMBURGER, ANNE W UNIVERSITY OF MARYLAND BALTIMORE BALTIMORE MD UNITED STATES NCI $462,585 Breast Cancer;Cancer;Genetics
THE MOLECULAR BASIS OF PREGNANCY-ASSOCIATED PROTECTION FROM BREAST CANCER 5RC2CA148507-02 2009-09-30 2010-09-01 31-Aug-11 2010 HANNON, GREGORY J COLD SPRING HARBOR LABORATORY COLD SPRING HARBOR NY UNITED STATES NCI $1,455,158 Breast Cancer;Cancer;Clinical Research;Estrogen;Genetics;Human Genome;Stem Cell Research;Stem Cell Research - Nonembryonic - Non-Human
THE MOLECULAR BASIS OF PREGNANCY-ASSOCIATED PROTECTION FROM BREAST CANCER 5RC2CA148507-02 2009-09-30 2010-09-01 31-Aug-11 2010 HANNON, GREGORY J COLD SPRING HARBOR LABORATORY COLD SPRING HARBOR NY UNITED STATES NCI Breast Cancer;Cancer;Clinical Research;Estrogen;Genetics;Human Genome;Stem Cell Research;Stem Cell Research - Nonembryonic - Non-Human
NOVEL MARKERS OF ANTHRACYCLINE-INDUCED MYOCARDIAL DAMAGE 1R21CA143787-01A1 2010-09-01 2010-09-01 31-Aug-11 2010 SHAPIRO, CHARLES L OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $327,090 Breast Cancer;Cancer;Cardiovascular;Clinical Research;Diagnostic Radiology;Heart Disease;Stem Cell Research;Stem Cell Research - Nonembryonic - Human
A CHEMICAL BIOLOGY NETWORK FOR PERSONALIZED MEDICINE 1RC2LM010994-01 2010-09-01 2010-09-01 31-Aug-11 2010 CARDOZO, TIMOTHY J NEW YORK UNIVERSITY SCHOOL OF MEDICINE NEW YORK NY UNITED STATES NLM $2,093,862 Networking and Information Technology R&D
THE TRANSCRIPTION FACTOR SLUG MAY DRIVE THE PROGRESSION OF AKT AND HER2/NEU 5U54CA143930-02 2010-09-01 31-Aug-11 2010 SLAMON, DENNIS J UNIVERSITY OF CALIFORNIA LOS ANGELES LOS ANGELES CA UNITED STATES NCI $38,869 Breast Cancer;Cancer;Genetics
PLANNING AND EVALUATION 5U54CA143931-02 2010-09-01 31-Aug-11 2010 VADGAMA, JAYDUTT V CHARLES R. DREW UNIVERSITY OF MED & SCI LOS ANGELES CA UNITED STATES NCI $42,448 Breast Cancer;Cancer;Genetics
MEASUREMENT IN DIVERSE POPULATIONS 5P01CA130818-03 2010-09-01 31-Aug-11 2010 PONCE, NINEZ ALAFRIZ UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $95,494 Bioengineering;Breast Cancer;Cancer
NONINVASIVE ASSESSMENT OF CANCER RESPONSIVENESS TO THERAPY BY USE OF ..... 5P50CA128323-03 2010-09-01 31-Aug-11 2010 HALLAHAN, DENNIS E VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $167,226 Cancer;Diagnostic Radiology
KINASE IMAGING 5P50CA086355-11 2010-09-01 31-Aug-11 2010 JOSEPHSON, LEE MASSACHUSETTS GENERAL HOSPITAL BOSTON MA UNITED STATES NCI $250,430 Bioengineering;Biotechnology;Cancer;Diagnostic Radiology;Nanotechnology
MOUSE MODELING AND ANIMAL DEVELOPMENT 7P01CA095426-09 2010-09-01 31-Aug-11 2010 MUTHUSAMY, NATARAJAN OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $252,597 Biotechnology;Cancer;Genetics;Lymphoma;Orphan Drug
ECONOMICS OF PERSONALIZED MEDICINE USING GENOMICS 5P01CA130818-03 2010-09-01 31-Aug-11 2010 LADABAUM, URI UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $320,985 Bioengineering;Breast Cancer;Cancer;Clinical Research;Cost Effectiveness Research;Health Services;Prevention
HSP90 AS A TARGET FOR MECHANISM-BASED THERAPY FOR CASTRATION-RESISTANT PROSTATE C 5P50CA092629-10 2010-09-01 31-Aug-11 2010 ROSEN, NEAL SLOAN-KETTERING INSTITUTE FOR CANCER RES NEW YORK NY UNITED STATES NCI $361,919 Aging;Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Prostate Cancer;Urologic Diseases
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21 7P01CA095426-09 2010-09-01 31-Aug-11 2010 CARSON, WILLIAM E. OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $414,913 Breast Cancer;Cancer;Immunization
UTILIZATION OF PERSONALIZED MEDICINE USING GENOMICS 5P01CA130818-03 2010-09-01 31-Aug-11 2010 HAAS, JENNIFER S UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $444,832 Bioengineering;Biotechnology;Breast Cancer;Cancer;Clinical Research;Genetics;Health Services
IMMUNOBIOLOGY OF P185 RECEPTOR 5R01CA055306-16 1992-05-01 2010-09-02 31-Jul-11 2010 GREENE, MARK I UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA UNITED STATES NCI $269,183 Biotechnology;Cancer;Immunization;Prevention
HIGH CAPACITY NANOCARRIERS FOR CANCER CHEMOTHERAPEUTICS 1U01CA151806-01 2010-09-02 2010-09-02 31-Jul-11 2010 KABANOV, ALEXANDER V UNIVERSITY OF NEBRASKA MEDICAL CENTER OMAHA NE UNITED STATES NCI $444,159 Bioengineering;Biotechnology;Breast Cancer;Cancer;Nanotechnology
INNATE IMMUNITY: ELUCIDATION AND MODULATION FOR CANCER THERAPY 7P01CA095426-09 2002-02-01 2010-09-07 31-Aug-11 2010 CALIGIURI, MICHAEL A OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $2,080,062 No NIH Category available.
MOLECULAR MECHANISMS OF RESISTANCE TO HER2 INHIBITORS IN BREAST CANCER 1K08CA143153-01A1 2010-09-07 2010-09-07 31-Aug-11 2010 REXER, BRENT N VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $163,080 Biotechnology;Breast Cancer;Cancer;Clinical Research
DEVELOPMENT OF TARGETED THERAPY FOR ERK PATHWAY IN BREAST CANCER 5K99CA139006-02 2009-09-30 2010-09-08 31-Aug-11 2010 BARTHOLOMEUSZ, CHANDRA UNIVERSITY OF TEXAS MD ANDERSON CAN CTR HOUSTON TX UNITED STATES NCI $115,239 Biotechnology;Breast Cancer;Cancer
ANTIBODY SHARED RESOURCES 2P30CA068485-14 2010-09-10 2010-09-10 31-Aug-11 2010 REYNOLDS, ALBERT B VANDERBILT UNIVERSITY NASHVILLE TN UNITED STATES NCI $109,306 Biotechnology;Cancer;Prevention
RESEARCH PROJECT 3: ROLE OF THE NF-KB/REL IN MAMMARY CARCINOGENESIS 5P01ES011624-09 2010-09-15 2010-09-15 30-Jun-11 2010 SONENSHEIN, GAIL E TUFTS UNIVERSITY BOSTON BOSTON MA UNITED STATES NIEHS $140,178 Breast Cancer;Cancer;Complementary and Alternative Medicine;Genetics;Nutrition
CYTOPLASMIC MISLOCALIZATION OF P27KIP1 AS A CAUSATIVE FACTOR AND PROGNOSTIC MARKE 1P50CA138293-01A1 2010-09-15 2010-09-15 31-Aug-11 2010 PORTER, PEGGY L FRED HUTCHINSON CANCER RESEARCH CENTER SEATTLE WA UNITED STATES NCI $1,023,777 Breast Cancer;Cancer;Estrogen
PROGNOSTIC AND PREDICTIVE GENE SETS IN HER2-POSITIVE BREAST CANCER:THE HERA TRIAL 5R21CA139428-02 2009-08-21 2010-09-16 31-Jul-11 2010 LEYLAND-JONES, BRIAN EMORY UNIVERSITY ATLANTA GA UNITED STATES NCI $174,733 Breast Cancer;Cancer;Genetics
PHASE I TRIAL WITH TWO HER-2 B CELL EPITOPE VACCINE IN PATIENTS WITH SOLID TUMORS 5R21CA135608-02 2009-08-25 2010-09-16 31-Jul-11 2010 KAUMAYA, PRAVIN T.P OHIO STATE UNIVERSITY COLUMBUS OH UNITED STATES NCI $330,000 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Immunization;Lung;Lung Cancer;Prevention;Vaccine Related
OPTIMIZATION OF NANOPARTICLE TARGETING IN OVARIAN AND BREAST CANCER 1U54CA151662-01 2010-09-01 2010-09-16 31-Aug-11 2010 GERNGROSS, TILLMAN DARTMOUTH COLLEGE HANOVER NH UNITED STATES NCI $1,111,562 Bioengineering;Biotechnology;Breast Cancer;Cancer;Nanotechnology
DISCOVERY PLATFORM FOR CANCER ANTIGENS 1R33CA143531-01A1 2010-09-16 2010-09-16 31-Aug-11 2010 CLAFFEY, KEVIN P. UNIVERSITY OF CONNECTICUT SCH OF MED/DNT FARMINGTON CT UNITED STATES NCI $313,665 Biotechnology;Breast Cancer;Cancer;Clinical Research;Prevention
APPLIED THERAPEUTICS & WHOLE ANIMAL IMAGING 2P30CA014051-39 2010-09-20 2010-09-20 30-Apr-11 2010 HEMANN, MICHAEL MASSACHUSETTS INSTITUTE OF TECHNOLOGY CAMBRIDGE MA UNITED STATES NCI $47,713 Cancer;Diagnostic Radiology
THERANOSTIC NANOMEDICINE FOR BREAST CANCER PREVENTION AND IMAGE-GUIDED THERAPY 1K99CA153948-01 2010-09-20 2010-09-20 31-Jul-11 2010 RAI, PRAKASH R MASSACHUSETTS GENERAL HOSPITAL BOSTON MA UNITED STATES NCI $121,312 Aging;Bioengineering;Breast Cancer;Cancer;Nanotechnology;Prevention
EGFR PEPTIDES AS VACCINES IN ANTI-TUMOR IMMUNITY 2R42CA128165-02A1 2007-04-01 2010-09-28 31-Aug-11 2010 MAMULA, MARK J. L2 DIAGNOSTICS, LLC NEW HAVEN CT UNITED STATES NCI $628,721 Biotechnology;Cancer;Immunization;Prevention;Vaccine Related
EGFR PEPTIDES AS VACCINES IN ANTI-TUMOR IMMUNITY 2R42CA128165-02A1 2007-04-01 2010-09-28 31-Aug-11 2010 MAMULA, MARK J. L2 DIAGNOSTICS, LLC NEW HAVEN CT UNITED STATES NCI Biotechnology;Cancer;Immunization;Prevention;Vaccine Related
BASTYR/UW ONCOMYCOLOGY TRANSLATIONAL RESEARCH CENTER 1U19AT006028-01A1 2010-09-29 2010-09-29 31-Aug-11 2010 STANDISH, LEANNA J BASTYR UNIVERSITY KENMORE WA UNITED STATES NCCAM $1,147,443 No NIH Category available.
FOLDAMERS: NOVEL LIGANDS FOR DIVERSE PROTEIN SURFACES 2R01GM074756-05 2005-08-01 2010-09-30 31-Jul-11 2010 SCHEPARTZ, ALANNA YALE UNIVERSITY NEW HAVEN CT UNITED STATES NIGMS $330,803 Biotechnology
DEVELOPMENT OF NOVEL IMMUNOCONJUGATES FOR APPLICATION IN CANCER THERAPEUTICS 5F32CA144213-02 2009-09-30 2010-09-30 29-Sep-11 2010 YOUNG, DOUGLAS DEAN SCRIPPS RESEARCH INSTITUTE LA JOLLA CA UNITED STATES NCI $47,606 Biotechnology;Cancer
AUGMENTING IMMUNITY VIA HER2-TARGETED IMMUNOTHERAPY AND PSK M.DISIS/L.STANDISH 1U19AT006028-01A1 2010-10-01 2010-10-01 31-Aug-11 2010 STANDISH, LEANNA J BASTYR UNIVERSITY KENMORE WA UNITED STATES NCCAM $590,985 Biotechnology;Breast Cancer;Cancer;Clinical Research;Clinical Trials;Complementary and Alternative Medicine;Immunization;Prevention;Vaccine Related
PHASE II STUDY OF DOCETAXEL & HERCEPTIN IN METASTATIC BREAST CANCER 5M01RR000042-40 1977-12-01 2000 BAKER, LAURENCE H UNIVERSITY OF MICHIGAN AT ANN ARBOR ANN ARBOR MI UNITED STATES NCRR No NIH Category available.
CPT11 AND TRASTUZUMAB IN ADVANCED COLORECTAL CANCER 5M01RR000056-39 1978-12-01 2000 RAMANTHAN, RAMESH UNIVERSITY OF PITTSBURGH AT PITTSBURGH PITTSBURGH PA UNITED STATES NCRR No NIH Category available.
BREAST CANCER 2U10CA025224-22 1982-01-01 2001 PEREZ, EDITH A MAYO CLINIC COLL OF MEDICINE, ROCHESTER ROCHESTER MN UNITED STATES NCI No NIH Category available.
DOCETAXEL & TRASTUZUMAB IN HER2 EXPRESSING METASTATIC BREAST CANCER 5M01RR000054-39 1991-12-01 2000 FOSS, FRANCINE M TUFTS MEDICAL CENTER BOSTON MA UNITED STATES NCRR No NIH Category available.
CORRELATION OF MARKER WITH RESPONSE TO CHEMOTHERAPY 2P50CA058223-09A1 1992-09-30 2001 CAREY, LISA A UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCI No NIH Category available.
DOCETAXEL & TRASTUZUMAB IN HER2 EXPRESSING METASTATIC BREAST CANCER 3M01RR000054-39S3 1999-12-01 2001 FOSS, FRANCINE M TUFTS MEDICAL CENTER BOSTON MA UNITED STATES NCRR No NIH Category available.
CPT11 AND TRASTUZUMAB IN ADVANCED COLORECTAL CANCER 5M01RR000056-40 2000-12-01 2001 RAMANTHAN, RAMESH UNIVERSITY OF PITTSBURGH AT PITTSBURGH PITTSBURGH PA UNITED STATES NCRR No NIH Category available.
CHARACTERIZATION AND PROFILING OF MICROMETASTASES 1U54CA090788-01 2001-09-26 2001 PARK, JOHN W UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI No NIH Category available.
EXPRESSION ANALYSIS OF ERBB RECEPTOR TARGETED THERAPIES 1U54CA090788-01 2001-09-26 2001 TRIPATHY, DEBASISH UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI No NIH Category available.
CPT11 AND TRASTUZUMAB IN ADVANCED COLORECTAL CANCER 5M01RR000056-41 2001-12-01 2002 RAMANTHAN, RAMESH UNIVERSITY OF PITTSBURGH AT PITTSBURGH PITTSBURGH PA UNITED STATES NCRR No NIH Category available.
CPT11 AND TRASTUZUMAB IN ADVANCED COLORECTAL CANCER 3M01RR000056-41S2 2001-12-01 2002 RAMANTHAN, RAMESH UNIVERSITY OF PITTSBURGH AT PITTSBURGH PITTSBURGH PA UNITED STATES NCRR No NIH Category available.
DOCETAXEL & TRASTUZUMAB IN HER2 EXPRESSING METASTATIC BREAST CANCER 5M01RR000054-41 2002-03-01 2002 FOSS, FRANCINE M TUFTS MEDICAL CENTER BOSTON MA UNITED STATES NCRR No NIH Category available.
CHARACTERIZATION AND PROFILING OF MICROMETASTASES 5U54CA090788-02 2002-05-01 2002 PARK, JOHN W UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $158,272 No NIH Category available.
EXPRESSION ANALYSIS OF ERBB RECEPTOR TARGETED THERAPIES 5U54CA090788-02 2002-05-01 2002 TRIPATHY, DEBASISH UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNITED STATES NCI $158,272 No NIH Category available.
CORRELATION OF MARKER WITH RESPONSE TO CHEMOTHERAPY 5P50CA058223-10 2002-09-13 2002 CAREY, LISA A UNIVERSITY OF NORTH CAROLINA CHAPEL HILL CHAPEL HILL NC UNITED STATES NCI No NIH Category available.
TAS::75 0849::TAS THE GOAL OF THIS PROJECT IS TO DEVELOP STC TRASTUZUMAB, A GEN Contract 2010-09-30 2010 LESZCZYNIECKA, MAGDALENA STC BIOLOGICS, INC CAMBRIDGE MA UNITED STATES NCI $299,881 Biotechnology;Breast Cancer;Cancer
USING GLYCOSYLTRANSFERASES FOR THE DEVELOPMENT OF TARGETED DRUG DELIVERY SYSTEM 1Z01BC010804-02 2008 QASBA, PRADMAN K DIVISION OF BASIC SCIENCES - NCI NCI $74,913 Bioengineering;Biotechnology;Breast Cancer;Cancer;Immunization
USING GLYCOSYLTRANSFERASES FOR THE DEVELOPMENT OF TARGETED DRUG DELIVERY SYSTEM 1Z01BC010804-01 2007 QASBA, PRADMAN K DIVISION OF BASIC SCIENCES - NCI NCI $80,021 No NIH Category available.
ADJUVANT THERAPY OF BREAST CANCER 1Z01BC010560-04 2007 SWAIN, SANDRA M DIVISION OF BASIC SCIENCES - NCI NCI $122,338 No NIH Category available.
IDENTIFICATION OF MOLECULAR TARGETS IN TRIPLE-NEGATIVE BREAST CANCER 1ZIABC010980-02 2009 LIPKOWITZ, STANLEY DIVISION OF BASIC SCIENCES - NCI NCI $183,633 Biotechnology;Breast Cancer;Cancer;Estrogen;Genetics
IDENTIFICATION OF MOLECULAR TARGETS IN TRIPLE-NEGATIVE BREAST CANCER 1Z01BC010980-01 2008 LIPKOWITZ, STANLEY DIVISION OF BASIC SCIENCES - NCI NCI $185,704 Biotechnology;Breast Cancer;Cancer;Estrogen;Genetics
MOLECULAR ALTERATIONS OF PRIMARY BREAST CANCER AND METASTASIS 1ZIABC010762-05 2010 MERINO, MARIA DIVISION OF BASIC SCIENCES - NCI NCI $220,179 Brain Cancer;Brain Disorders;Breast Cancer;Cancer
MOLECULAR ALTERATIONS OF PRIMARY BREAST CANCER AND METASTASIS 1Z01BC010762-03 2008 MERINO NEUMANN, MARIA DIVISION OF BASIC SCIENCES - NCI NCI $224,353 Brain Cancer;Brain Disorders;Breast Cancer;Cancer;Neurosciences
UTILIZING GLYCOSYLTRANSFERASES FOR BIOCONJUGATION 1ZIABC010742-04 2009 QASBA, PRADMAN K DIVISION OF BASIC SCIENCES - NCI NCI $253,783 Bioengineering;Biotechnology;Cancer
MOLECULAR ALTERATIONS OF PRIMARY BREAST CANCER AND METASTASIS 1ZIABC010762-04 2009 MERINO NEUMANN, MARIA DIVISION OF BASIC SCIENCES - NCI NCI $260,049 Biotechnology;Brain Cancer;Brain Disorders;Breast Cancer;Cancer;Genetics
UTILIZING GLYCOSYLTRANSFERASES FOR BIOCONJUGATION 1Z01BC010742-03 2008 QASBA, PRADMAN K DIVISION OF BASIC SCIENCES - NCI NCI $327,744 Bioengineering;Biotechnology;Cancer
UTILIZING GLYCOSYLTRANSFERASES FOR BIOCONJUGATION 1Z01BC010742-02 2007 QASBA, PRADMAN K DIVISION OF BASIC SCIENCES - NCI NCI $350,089 No NIH Category available.
DEVELOPMENTAL THERAPEUTICS 1Z01BC010435-07 2007 SWAIN, SANDRA M DIVISION OF BASIC SCIENCES - NCI NCI $404,315 No NIH Category available.
INFLAMMATORY BREAST CANCER 1Z01SC010097-08 2007 SWAIN, SANDRA M DIVISION OF CLINICAL SCIENCES - NCI NCI $416,574 No NIH Category available.
TRAIL-INDUCED CELL DEATH IN BREAST CANCER CELLS 1ZIASC007263-17 2009 LIPKOWITZ, STANLEY DIVISION OF CLINICAL SCIENCES - NCI NCI $428,477 Breast Cancer;Cancer;Ovarian Cancer
TRAIL-INDUCED CELL DEATH IN BREAST CANCER CELLS 1Z01SC007263-16 2008 LIPKOWITZ, STANLEY DIVISION OF CLINICAL SCIENCES - NCI NCI $433,310 Breast Cancer;Cancer;Ovarian Cancer
MOLECULAR IMAGING AND TARGETED THERAPY OF HER2-POSITIVE BREAST CANCERS 1Z01BC010727-02 2007 CAPALA, JACEK DIVISION OF BASIC SCIENCES - NCI NCI $548,064 No NIH Category available.
MOLECULAR ANALYSIS OF BREAST CANCER METASTASIS TO THE BRAIN 1Z01BC010538-06 2008 STEEG, PATRICIA DIVISION OF BASIC SCIENCES - NCI NCI $584,959 Biotechnology;Brain Cancer;Brain Disorders;Breast Cancer;Cancer;Genetics;Neurosciences;Orphan Drug
MOLECULAR IMAGING AND TARGETED THERAPY OF HER2-POSITIVE BREAST CANCERS 1Z01BC010727-03 2008 CAPALA, JACEK DIVISION OF BASIC SCIENCES - NCI NCI $654,233 Bioengineering;Biotechnology;Breast Cancer;Cancer;Diagnostic Radiology;Nanotechnology
MOLECULAR ANALYSIS OF BREAST CANCER METASTASIS TO THE BRAIN 1Z01BC010538-05 2007 STEEG, PATRICIA DIVISION OF BASIC SCIENCES - NCI NCI $716,369 No NIH Category available.
MOLECULAR IMAGING AND TARGETED THERAPY OF HER2-POSITIVE BREAST CANCERS 1ZIABC010727-04 2009 CAPALA, JACEK DIVISION OF BASIC SCIENCES - NCI NCI $755,654 Bioengineering;Biotechnology;Breast Cancer;Cancer;Diagnostic Radiology;Nanotechnology
GROWTH FACTOR IMAGING 1Z01BC010656-03 2007 CHOYKE, PETER L DIVISION OF BASIC SCIENCES - NCI NCI $768,482 No NIH Category available.
METAL CHELATE CONJUGATED MONOCLONAL ANTIBODIES FOR TUMOR DIAGNOSIS AND THERAPY 1Z01SC006353-26 2008 BRECHBIEL, MARTIN W DIVISION OF CLINICAL SCIENCES - NCI NCI $814,632 Bioengineering;Biotechnology;Cancer;Clinical Research;Digestive Diseases;Orphan Drug;Ovarian Cancer
INTRACELLULAR IN VIVO IMAGING 1ZIABC010657-06 2010 CHOYKE, PETER L DIVISION OF BASIC SCIENCES - NCI NCI $837,139 Bioengineering;Cancer;Diagnostic Radiology;HIV/AIDS;Nanotechnology
GROWTH FACTOR IMAGING 1Z01BC010656-04 2008 CHOYKE, PETER L DIVISION OF BASIC SCIENCES - NCI NCI $880,575 Bioengineering;Biotechnology;Breast Cancer;Cancer;Clinical Research;Diagnostic Radiology;Nanotechnology;Orphan Drug
METAL CHELATE CONJUGATED MONOCLONAL ANTIBODIES FOR TUMOR DIAGNOSIS AND THERAPY 1ZIASC006353-28 2010 BRECHBIEL, MARTIN W DIVISION OF CLINICAL SCIENCES - NCI NCI $906,883 Bioengineering;Biotechnology;Cancer;Diagnostic Radiology
METAL CHELATE CONJUGATED MONOCLONAL ANTIBODIES FOR TUMOR DIAGNOSIS AND THERAPY 1Z01SC006353-25 2007 BRECHBIEL, MARTIN W DIVISION OF CLINICAL SCIENCES - NCI NCI $959,255 No NIH Category available.
METAL CHELATE CONJUGATED MONOCLONAL ANTIBODIES FOR TUMOR DIAGNOSIS AND THERAPY 1ZIASC006353-27 2009 BRECHBIEL, MARTIN W DIVISION OF CLINICAL SCIENCES - NCI NCI $1,165,814 Biotechnology;Cancer;Clinical Research
INTRACELLULAR IN VIVO IMAGING 1ZIABC010657-05 2009 CHOYKE, PETER L DIVISION OF BASIC SCIENCES - NCI NCI $1,181,188 Cancer;Diagnostic Radiology
SIGNAL TRANSDUCTION IN EPITHELIAL CANCER CELLS 1Z01SC007263-15 2007 LIPKOWITZ, STANLEY DIVISION OF CLINICAL SCIENCES - NCI NCI $1,314,511 No NIH Category available.
GROWTH FACTOR IMAGING 1ZIABC010656-06 2010 CHOYKE, PETER L DIVISION OF BASIC SCIENCES - NCI NCI $1,674,279 Bioengineering;Biotechnology;Breast Cancer;Cancer;Clinical Research;Diagnostic Radiology;Nanotechnology
INTRACELLULAR IN VIVO IMAGING 1Z01BC010657-04 2008 CHOYKE, PETER L DIVISION OF BASIC SCIENCES - NCI NCI $1,761,151 Cancer;Diagnostic Radiology
ANTIGEN-SPECIFIC T-CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS 1Z01SC004020-31 2008 BERZOFSKY, JAY A DIVISION OF CLINICAL SCIENCES - NCI NCI $1,800,256 Biotechnology;Breast Cancer;Cancer;Clinical Research;Emerging Infectious Diseases;Immunization;Infectious Diseases;Orphan Drug;Prevention;Vaccine Related
ANTIGEN-SPECIFIC T-CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS 1Z01SC004020-30 2007 BERZOFSKY, JAY A DIVISION OF CLINICAL SCIENCES - NCI NCI $2,029,401 No NIH Category available.
GROWTH FACTOR IMAGING 1ZIABC010656-05 2009 CHOYKE, PETER L DIVISION OF BASIC SCIENCES - NCI NCI $2,362,374 Bioengineering;Biotechnology;Breast Cancer;Cancer;Clinical Research;Diagnostic Radiology;Nanotechnology
KINASE ACTIVATION AND CONTROL OF APOPTOSIS IN BREAST CAN 1Z01SC020293-04 2002 DENNIS, PHILLIP A. DIVISION OF CLINICAL SCIENCES - NCI NCI No NIH Category available.
KINASE ACTIVATION AND CONTROL OF APOPTOSIS IN BREAST CAN 1Z01SC020293-03 2001 DENNIS, PHILLIP A. DIVISION OF CLINICAL SCIENCES - NCI NCI No NIH Category available.
MOLECULAR CONTROL OF GROWTH, DIFFERENTIATION, AND DEATH 1Z01SC007263-12 2004 LIPKOWITZ, STANLEY DIVISION OF CLINICAL SCIENCES - NCI NCI No NIH Category available.
MOLECULAR CONTROL OF GROWTH, DIFFERENTIATION, AND DEATH 1Z01SC007263-11 2003 LIPKOWITZ, STANLEY DIVISION OF CLINICAL SCIENCES - NCI NCI No NIH Category available.
MOLECULAR CONTROL OF GROWTH, DIFFERENTIATION, AND DEATH 1Z01SC007263-10 2002 LIPKOWITZ, STANLEY DIVISION OF CLINICAL SCIENCES - NCI NCI No NIH Category available.
MOLECULAR CONTROL OF GROWTH, DIFFERENTIATION, AND DEATH 1Z01SC007263-09 2001 LIPKOWITZ, STANLEY DIVISION OF CLINICAL SCIENCES - NCI NCI No NIH Category available.
MOLECULAR ANALYSIS OF BREAST CANCER METASTASIS TO THE BR 1Z01BC010538-03 2005 STEEG, PATRICIA DIVISION OF BASIC SCIENCES - NCI NCI No NIH Category available.
DEVELOPMENTAL THERAPEUTICS 1Z01BC010435-06 2006 SWAIN, SANDRA M DIVISION OF BASIC SCIENCES - NCI NCI No NIH Category available.
ADJUVANT THERAPY OF BREAST CANCER 1Z01BC010560-03 2006 SWAIN, SANDRA M DIVISION OF BASIC SCIENCES - NCI NCI No NIH Category available.